| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.19e-06 | 26 | 199 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion binding | 8.86e-06 | 14 | 199 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 ERBB3 RIPK2 IP6K1 DGKH LMTK3 CCNK PTK2 MAP3K5 CDKL5 MET DLG2 BRSK2 CILK1 PAPSS2 ITPKC EGFR CSK EPHA1 MAP3K2 | 8.22e-05 | 764 | 199 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 ERBB3 RIPK2 IP6K1 DGKH LMTK3 CCNK PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 PAPSS2 ITPKC EGFR CSK EPHA1 MAP3K2 | 9.19e-05 | 709 | 199 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.05e-04 | 145 | 199 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.20e-04 | 26 | 199 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.40e-04 | 27 | 199 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.52e-04 | 11 | 199 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 ERBB3 RIPK2 IP6K1 DGKH LMTK3 CCNK PTK2 MAP3K5 PARP6 CDKL5 MET DLG2 PIGO BRSK2 CILK1 PAPSS2 ITPKC EGFR CSK EPHA1 MAP3K2 | 1.76e-04 | 938 | 199 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.02e-04 | 120 | 199 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.95e-04 | 3 | 199 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.76e-04 | 65 | 199 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.98e-04 | 17 | 199 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.12e-04 | 18 | 199 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 9.69e-04 | 5 | 199 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | nucleobase binding | 9.69e-04 | 5 | 199 | 2 | GO:0002054 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 ERBB3 RIPK2 LMTK3 CCNK PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 EGFR CSK EPHA1 MAP3K2 | 1.04e-03 | 600 | 199 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.25e-03 | 210 | 199 | 8 | GO:0019903 | |
| GeneOntologyBiologicalProcess | blood circulation | ABAT ABR ACE PTGS1 PTK2 STAT1 MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A GNAS NEDD4L ARHGAP35 AR TGFB2 EGFR TRPV4 EPAS1 | 1.32e-06 | 648 | 199 | 21 | GO:0008015 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | EPHB2 LGALS9C LGALS9B RIPK2 MAML1 HLX GCNT2 ACE ITGB3 TRIP10 PTK2 STAT1 MAP3K5 PARP6 CDKL5 MET BMP10 ACTL6B GNAS RB1 AR BTN2A1 TGFB2 GRIP1 DUOXA1 MEGF8 EGFR TLE6 SMARCE1 | 1.73e-06 | 1141 | 199 | 29 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | EPHB2 LGALS9C LGALS9B RIPK2 HLX ACE ITGB3 PTK2 PARP6 CDKL5 MET ACTL6B GNAS RB1 BTN2A1 GRIP1 MEGF8 EGFR TLE6 SMARCE1 | 2.22e-06 | 614 | 199 | 20 | GO:0010720 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 KIFBP ITGB3 PTK2 PARP6 CDKL5 MET FAT1 CDH20 HECW2 SCFD1 DIP2B NEDD4L RB1 SLC26A5 CAPZB BRSK2 ARHGAP35 CDH19 AR TGFB2 GRIP1 FRY MEGF8 EGFR CTTN CDH7 CDH12 ZMYM6 | 4.21e-06 | 1194 | 199 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LGALS9C LGALS9B ABCA12 RIPK2 HLX ADGRV1 GCNT2 ITGA5 ITGB3 PTK2 FAT1 CDH20 DLG2 ACTL6B GNAS COL19A1 CDH19 BTN2A1 TGFB2 CELSR1 EGFR CSK SMARCE1 TRPV4 IGSF21 CDH7 CDH12 | 5.27e-06 | 1077 | 199 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | circulatory system process | ABAT ABR ACE PTGS1 PTK2 STAT1 MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A GNAS NEDD4L ARHGAP35 AR TGFB2 EGFR TRPV4 EPAS1 | 8.96e-06 | 733 | 199 | 21 | GO:0003013 |
| GeneOntologyBiologicalProcess | actin filament-based process | ABR NEB ITGB3 TRIP10 MET FAT1 BMP10 SCN1A SCN2A SCN3A SCN9A BAIAP2L2 FLNC NEDD4L CAPZB BRSK2 ARHGAP35 TGFB2 CELSR1 TLE6 TRPV4 CTTN EPHA1 | 2.54e-05 | 912 | 199 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | negative regulation of small GTPase mediated signal transduction | 4.58e-05 | 67 | 199 | 6 | GO:0051058 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | ABAT ACE ITGB3 STAT1 ADRA1A EHMT2 UGT2B4 UGT2B10 ALDH3A1 GNAS DNMT1 DPYD RB1 SLC26A5 TXNIP EGFR | 5.32e-05 | 525 | 199 | 16 | GO:0009410 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 6.35e-05 | 103 | 199 | 7 | GO:0048814 | |
| GeneOntologyBiologicalProcess | muscle system process | ABAT CMYA5 TRIP10 PTGS1 PTK2 MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A NEDD4L AR TRPV4 CTTN | 8.61e-05 | 547 | 199 | 16 | GO:0003012 |
| GeneOntologyBiologicalProcess | negative regulation of Rho protein signal transduction | 1.24e-04 | 27 | 199 | 4 | GO:0035024 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | LGALS9C LGALS9B RIPK2 HLX ITGB3 ACTL6B GNAS RB1 BTN2A1 SMARCE1 | 1.27e-04 | 242 | 199 | 10 | GO:1903708 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | LGALS9C LGALS9B RIPK2 HLX ITGB3 ACTL6B GNAS RB1 BTN2A1 SMARCE1 | 1.27e-04 | 242 | 199 | 10 | GO:1902107 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPHB2 ABR ITGA5 ITGB3 PTK2 STAT1 PARP6 CDKL5 MET HECW2 DIP2B NEDD4L SLC26A5 CAPZB BRSK2 ARHGAP35 AR TGFB2 GRIP1 CELSR1 GTF2I MEGF8 ZMYM6 EPHA1 | 1.41e-04 | 1090 | 199 | 24 | GO:0022603 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.45e-04 | 246 | 199 | 10 | GO:0045216 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | ADGRV1 ITGB3 PTK2 STAT1 SCN1A SCN9A SLC26A5 TXNIP EGFR TRPV4 | 1.49e-04 | 247 | 199 | 10 | GO:0009612 |
| GeneOntologyBiologicalProcess | heart contraction | ACE MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A NEDD4L TGFB2 EPAS1 | 1.58e-04 | 298 | 199 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | EPHB2 PTK2 PARP6 CDKL5 MET NEDD4L SLC26A5 CAPZB ARHGAP35 GRIP1 ZMYM6 | 1.78e-04 | 302 | 199 | 11 | GO:0022604 |
| GeneOntologyBiologicalProcess | tube development | EPHB2 ACAT1 ABCA12 HLX ITGA5 ACE ITGB3 PTK2 PHGDH STAT1 MET SALL2 BAG6 TNS3 ALPI COL8A1 RB1 BBS5 ARHGAP35 AR TGFB2 CELSR1 GTF2I MEGF8 EGFR RTL1 EPAS1 EPHA1 | 1.98e-04 | 1402 | 199 | 28 | GO:0035295 |
| GeneOntologyBiologicalProcess | heart process | ACE MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A NEDD4L TGFB2 EPAS1 | 2.16e-04 | 309 | 199 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 2.23e-04 | 167 | 199 | 8 | GO:0007043 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.23e-04 | 167 | 199 | 8 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of GTP binding | 2.36e-04 | 13 | 199 | 3 | GO:1904424 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | LGALS9C LGALS9B ITGA5 FAT1 CDH20 CDH19 TGFB2 CELSR1 IGSF21 CDH7 CDH12 | 2.42e-04 | 313 | 199 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB2 LGALS9C ERBB3 LGALS9B ABCA12 RIPK2 HLX GCNT2 ITGA5 ITGB3 PTK2 ACTL6B COL8A1 CBLL2 LAMA4 BTN2A1 TGFB2 CSK SMARCE1 TRPV4 EPHA1 | 2.57e-04 | 927 | 199 | 21 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 2.61e-04 | 59 | 199 | 5 | GO:0045933 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.68e-04 | 217 | 199 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin biosynthetic process | 2.76e-04 | 3 | 199 | 2 | GO:0045726 | |
| GeneOntologyBiologicalProcess | positive regulation of prolactin secretion | 2.76e-04 | 3 | 199 | 2 | GO:1902722 | |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 KIFBP ABR HLX ITGA5 BCOR ACE CCNK PHGDH SALL2 DLG2 GNAS BAG6 ALPI LAMA4 AKIRIN2 BBS5 ARHGAP35 AR TGFB2 CELSR1 GTF2I MEGF8 EGFR RTL1 TLE6 TOP2A EPAS1 | 2.96e-04 | 1437 | 199 | 28 | GO:0009790 |
| GeneOntologyBiologicalProcess | adherens junction organization | 3.05e-04 | 61 | 199 | 5 | GO:0034332 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 3.29e-04 | 62 | 199 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | sodium ion transport | CLCNKB HECW2 SCN1A SCN2A SCN3A SCN9A GNAS NEDD4L SLC9A5 ATP1B3 | 3.54e-04 | 275 | 199 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | regulation of cell development | EPHB2 LGALS9C LGALS9B RIPK2 HLX ACE ITGB3 PTK2 STAT1 PARP6 CDKL5 MET ACTL6B GNAS DIP2B LILRA1 RB1 BTN2A1 GRIP1 MEGF8 EGFR TLE6 SMARCE1 | 3.82e-04 | 1095 | 199 | 23 | GO:0060284 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.89e-04 | 36 | 199 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle contraction | 3.89e-04 | 36 | 199 | 4 | GO:0045987 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 4.73e-04 | 67 | 199 | 5 | GO:0050775 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 5.05e-04 | 144 | 199 | 7 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 5.18e-04 | 104 | 199 | 6 | GO:0071677 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | LGALS9C LGALS9B RIPK2 HLX GCNT2 ITGA5 ITGB3 PTK2 ACTL6B COL8A1 BTN2A1 TGFB2 CSK SMARCE1 EPHA1 | 5.21e-04 | 579 | 199 | 15 | GO:0045785 |
| GeneOntologyBiologicalProcess | muscle contraction | ABAT PTGS1 MET ADRA1A BMP10 SCN1A SCN2A SCN3A SCN9A NEDD4L TRPV4 CTTN | 5.33e-04 | 400 | 199 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 5.42e-04 | 69 | 199 | 5 | GO:0010770 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 5.44e-04 | 17 | 199 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 5.49e-04 | 4 | 199 | 2 | GO:0043322 | |
| GeneOntologyBiologicalProcess | positive regulation of GTP binding | 5.49e-04 | 4 | 199 | 2 | GO:1904426 | |
| GeneOntologyCellularComponent | anchoring junction | ZNF185 ITGA5 ITGB3 PTK2 FOCAD FAT1 UBA1 CDH20 MLC1 SCN1A SCN2A DLG2 BAIAP2L2 TNS3 FLNC TNS2 CDH19 SLC9A5 EGFR CSK TRPV4 CTTN IGSF21 CDH7 CDH12 | 7.33e-06 | 976 | 200 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.76e-05 | 17 | 200 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | cell-cell junction | ITGA5 ITGB3 PTK2 FAT1 UBA1 CDH20 MLC1 SCN1A SCN2A DLG2 BAIAP2L2 CDH19 CSK TRPV4 IGSF21 CDH7 CDH12 | 5.73e-05 | 591 | 200 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | sodium channel complex | 1.60e-04 | 29 | 200 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | catenin complex | 2.37e-04 | 32 | 200 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-vitronectin complex | 2.72e-04 | 3 | 200 | 2 | GO:0071062 | |
| GeneOntologyCellularComponent | focal adhesion | ZNF185 ITGA5 ITGB3 PTK2 FOCAD FAT1 TNS3 FLNC TNS2 SLC9A5 EGFR TRPV4 CTTN | 2.76e-04 | 431 | 200 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | cell leading edge | ADGRV1 ITGA5 ITGB3 PTK2 CDKL5 FAT1 GNAS DAGLA CAPZB SLC9A5 DUOXA1 EGFR TRPV4 CTTN | 3.43e-04 | 500 | 200 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | cell-substrate junction | ZNF185 ITGA5 ITGB3 PTK2 FOCAD FAT1 TNS3 FLNC TNS2 SLC9A5 EGFR TRPV4 CTTN | 3.58e-04 | 443 | 200 | 13 | GO:0030055 |
| GeneOntologyCellularComponent | cilium | ADGRV1 SAXO1 ACE PTGS1 PTK2 CDKL5 MET SLC26A8 CLCN4 DNHD1 DNAH2 CILK1 BBS5 ARHGAP35 GARIN2 EYS TRPV4 ATP1B3 CFAP46 DNAH11 | 4.05e-04 | 898 | 200 | 20 | GO:0005929 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 4.95e-04 | 238 | 200 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | basal plasma membrane | SLC43A2 ERBB3 ACE PTK2 MET CLCNKA MLC1 DLG2 SLC26A5 EGFR ATP1B3 | 6.35e-04 | 354 | 200 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | axon | EPHB2 ABR LMTK3 STAT1 CDKL5 SCN1A SCN2A SCN3A SCN9A PYGB DLG2 DAGLA DIP2B BRSK2 AR TGFB2 GRIP1 TRPV4 CTTN | 9.51e-04 | 891 | 200 | 19 | GO:0030424 |
| GeneOntologyCellularComponent | leading edge membrane | 9.66e-04 | 210 | 200 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | basal part of cell | SLC43A2 ERBB3 ACE PTK2 MET CLCNKA MLC1 DLG2 SLC26A5 EGFR ATP1B3 | 1.08e-03 | 378 | 200 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | sperm flagellum | 1.09e-03 | 214 | 200 | 8 | GO:0036126 | |
| GeneOntologyCellularComponent | myofibril | 1.31e-03 | 273 | 200 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ERBB3 ITGA5 ITGB3 CDH20 SCN1A SCN2A SCN3A SCN9A DLG2 GNAS LILRA1 CDH19 EGFR CTTN ATP1B3 CDH7 CDH12 | 1.50e-03 | 785 | 200 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic membrane | EPHB2 ERBB3 ITGA5 ITGB3 MET ADRA1A DLG2 DAGLA GRIP1 SLC9A5 IGSF21 | 1.87e-03 | 405 | 200 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.97e-03 | 290 | 200 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.07e-03 | 137 | 200 | 6 | GO:0019897 | |
| HumanPheno | Calcaneovalgus deformity | 5.49e-08 | 34 | 85 | 8 | HP:0001848 | |
| HumanPheno | Deformed tarsal bones | 7.03e-08 | 35 | 85 | 8 | HP:0008119 | |
| HumanPheno | Abnormality of the calcaneus | 3.06e-07 | 57 | 85 | 9 | HP:0008364 | |
| HumanPheno | Limited knee extension | 4.04e-06 | 27 | 85 | 6 | HP:0003066 | |
| HumanPheno | Poor fine motor coordination | 1.57e-05 | 69 | 85 | 8 | HP:0007010 | |
| HumanPheno | Limitation of knee mobility | 1.99e-05 | 35 | 85 | 6 | HP:0010501 | |
| HumanPheno | Infection-related seizure | CEP85L ADGRV1 CDKL5 SCN1A SCN2A SCN3A SCN9A HERC2 DPYD CILK1 SETBP1 | 2.38e-05 | 145 | 85 | 11 | HP:0032892 |
| HumanPheno | Seizure precipitated by febrile infection | CEP85L ADGRV1 CDKL5 SCN1A SCN2A SCN3A SCN9A HERC2 DPYD CILK1 SETBP1 | 2.38e-05 | 145 | 85 | 11 | HP:0032894 |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | CEP85L ADGRV1 CDKL5 SCN1A SCN2A SCN3A SCN9A HERC2 DPYD CILK1 SETBP1 | 2.38e-05 | 145 | 85 | 11 | HP:0002373 |
| HumanPheno | Abnormality of the calf | ADGRV1 NEB BCOR MET SCN1A SCN2A SCN9A HERC2 FLNC RB1 CILK1 PAPSS2 AR GTF2I MEGF8 RTL1 SETBP1 TRPV4 | 4.52e-05 | 384 | 85 | 18 | HP:0002981 |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 4.60e-05 | 13 | 85 | 4 | HP:0007058 | |
| HumanPheno | Interictal epileptiform activity | ABAT ADGRV1 PHGDH CDKL5 CLCN4 SCN1A SCN2A SCN3A SCN9A ACTL6B VARS1 PIGO DPYD NEDD4L CILK1 SETBP1 | 5.74e-05 | 319 | 85 | 16 | HP:0011182 |
| HumanPheno | Interictal EEG abnormality | ABAT ADGRV1 PHGDH CDKL5 CLCN4 SCN1A SCN2A SCN3A SCN9A ACTL6B VARS1 PIGO DPYD NEDD4L CILK1 SETBP1 | 7.19e-05 | 325 | 85 | 16 | HP:0025373 |
| HumanPheno | Poor motor coordination | 7.30e-05 | 85 | 85 | 8 | HP:0002275 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 8.57e-05 | 15 | 85 | 4 | HP:0007207 | |
| HumanPheno | Generalized non-motor (absence) seizure | CEP85L ADGRV1 PHGDH CDKL5 CLCN4 SCN1A SCN2A SCN9A NEDD4L CILK1 MEGF8 | 1.41e-04 | 176 | 85 | 11 | HP:0002121 |
| HumanPheno | Atypical absence status epilepticus | 1.46e-04 | 17 | 85 | 4 | HP:0011151 | |
| HumanPheno | Recurrent maladaptive behavior | ACAT1 CEP85L ABCA12 CHD3 ADGRV1 BCOR CCNK PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 CLCNKA CLCNKB HPD HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 VARS1 DNMT1 DPYD CILK1 BBS5 AR SLC3A1 GTF2I ASXL3 SETBP1 SMARCE1 EPAS1 | 1.82e-04 | 1293 | 85 | 37 | HP:5200241 |
| HumanPheno | Visually-induced seizure | 1.85e-04 | 18 | 85 | 4 | HP:0020216 | |
| HumanPheno | Abnormal choroid plexus morphology | 1.85e-04 | 18 | 85 | 4 | HP:0007376 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.85e-04 | 18 | 85 | 4 | HP:0032860 | |
| HumanPheno | Obsessive-compulsive trait | 1.89e-04 | 33 | 85 | 5 | HP:0008770 | |
| HumanPheno | Autistic behavior | CEP85L CHD3 ADGRV1 BCOR CCNK SCAF4 CDKL5 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B HERC2 ASCC3 PIGO DPYD BBS5 GTF2I RTL1 ASXL3 SETBP1 SMARCE1 | 1.93e-04 | 678 | 85 | 24 | HP:0000729 |
| HumanPheno | Photosensitive myoclonic seizure | 2.36e-04 | 8 | 85 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 2.36e-04 | 8 | 85 | 3 | HP:0200048 | |
| HumanPheno | Abnormally increased volition | ACAT1 CEP85L ABCA12 CHD3 BCOR PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HPD HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I ASXL3 SETBP1 SMARCE1 | 2.42e-04 | 869 | 85 | 28 | HP:5200263 |
| HumanPheno | Non-convulsive status epilepticus without coma | 2.85e-04 | 20 | 85 | 4 | HP:0032671 | |
| HumanPheno | Cortical dysplasia | 3.01e-04 | 56 | 85 | 6 | HP:0002539 | |
| HumanPheno | Restricted or repetitive behaviors or interests | CEP85L CHD3 ADGRV1 CCNK CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN9A HERC2 ASCC3 VARS1 GTF2I ASXL3 | 3.08e-04 | 368 | 85 | 16 | HP:0031432 |
| HumanPheno | Talipes valgus | 3.48e-04 | 21 | 85 | 4 | HP:0004684 | |
| HumanPheno | Abnormal tibia morphology | 3.67e-04 | 107 | 85 | 8 | HP:0002992 | |
| HumanPheno | Non-motor seizure | CEP85L ADGRV1 PHGDH CDKL5 CLCN4 SCN1A SCN2A SCN9A NEDD4L CILK1 MEGF8 | 3.80e-04 | 197 | 85 | 11 | HP:0033259 |
| HumanPheno | Perseverative thought | CEP85L CHD3 ADGRV1 CCNK CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN9A HERC2 ASCC3 VARS1 GTF2I ASXL3 | 4.05e-04 | 377 | 85 | 16 | HP:0030223 |
| HumanPheno | Reflex seizure | 4.20e-04 | 22 | 85 | 4 | HP:0020207 | |
| HumanPheno | Disinhibition | CEP85L ABCA12 CHD3 BCOR PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I ASXL3 SETBP1 SMARCE1 | 4.45e-04 | 807 | 85 | 26 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CEP85L ABCA12 CHD3 BCOR PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I ASXL3 SETBP1 SMARCE1 | 4.45e-04 | 807 | 85 | 26 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CEP85L ABCA12 CHD3 BCOR PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I ASXL3 SETBP1 SMARCE1 | 4.45e-04 | 807 | 85 | 26 | HP:5200123 |
| HumanPheno | Social disinhibition | CEP85L ABCA12 CHD3 BCOR PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I ASXL3 SETBP1 SMARCE1 | 4.45e-04 | 807 | 85 | 26 | HP:5200029 |
| HumanPheno | EEG with generalized epileptiform discharges | ABAT ADGRV1 PHGDH CDKL5 SCN1A SCN2A SCN3A SCN9A ACTL6B PIGO NEDD4L CILK1 SETBP1 | 4.63e-04 | 270 | 85 | 13 | HP:0011198 |
| HumanPheno | Choroid plexus cyst | 4.94e-04 | 10 | 85 | 3 | HP:0002190 | |
| HumanPheno | Tibial torsion | 5.02e-04 | 23 | 85 | 4 | HP:0100694 | |
| HumanPheno | Abnormal social development | CEP85L ABCA12 CHD3 BCOR CCNK PHGDH SCAF4 FOCAD CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN3A SCN9A ACTL6B GNAS HERC2 ASCC3 DNMT1 DPYD CILK1 GTF2I RTL1 ASXL3 SETBP1 SMARCE1 | 5.12e-04 | 908 | 85 | 28 | HP:0025732 |
| HumanPheno | Disordered formal thought process | CEP85L CHD3 ADGRV1 CCNK CDKL5 ALKBH8 CLCN4 HECW2 SCN1A SCN2A SCN9A HERC2 ASCC3 VARS1 GTF2I ASXL3 | 5.28e-04 | 386 | 85 | 16 | HP:0025769 |
| HumanPheno | Abnormal knee physiology | 5.58e-04 | 87 | 85 | 7 | HP:0034670 | |
| MousePheno | petechiae | 5.79e-06 | 11 | 165 | 4 | MP:0008816 | |
| MousePheno | pulmonary artery hypoplasia | 5.79e-06 | 11 | 165 | 4 | MP:0010460 | |
| Domain | Na_trans_cytopl | 1.92e-07 | 6 | 201 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 1.92e-07 | 6 | 201 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 2.60e-06 | 10 | 201 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 2.60e-06 | 10 | 201 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 2.60e-06 | 10 | 201 | 4 | PF06512 | |
| Domain | - | 8.54e-06 | 95 | 201 | 8 | 2.60.120.200 | |
| Domain | PROTEIN_KINASE_TYR | 9.97e-06 | 97 | 201 | 8 | PS00109 | |
| Domain | RNA_pol_II-bd | 4.16e-05 | 7 | 201 | 3 | IPR006903 | |
| Domain | CTD_bind | 4.16e-05 | 7 | 201 | 3 | PF04818 | |
| Domain | Tyr_kinase_cat_dom | 4.58e-05 | 88 | 201 | 7 | IPR020635 | |
| Domain | TyrKc | 4.58e-05 | 88 | 201 | 7 | SM00219 | |
| Domain | RPR | 6.61e-05 | 8 | 201 | 3 | SM00582 | |
| Domain | CID_dom | 6.61e-05 | 8 | 201 | 3 | IPR006569 | |
| Domain | CID | 6.61e-05 | 8 | 201 | 3 | PS51391 | |
| Domain | Pkinase_Tyr | 7.85e-05 | 129 | 201 | 8 | PF07714 | |
| Domain | Tyr_kinase_AS | 8.54e-05 | 97 | 201 | 7 | IPR008266 | |
| Domain | Cl-channel_core | 9.83e-05 | 9 | 201 | 3 | IPR014743 | |
| Domain | - | 9.83e-05 | 9 | 201 | 3 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 9.83e-05 | 9 | 201 | 3 | PF00654 | |
| Domain | Cl-channel_volt-gated | 9.83e-05 | 9 | 201 | 3 | IPR001807 | |
| Domain | Cl_channel-K | 1.15e-04 | 2 | 201 | 2 | IPR002250 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.26e-04 | 138 | 201 | 8 | IPR001245 | |
| Domain | ConA-like_dom | LGALS9C LGALS9B ADGRV1 CMYA5 FAT1 COL19A1 LAMA4 BTN2A1 EYS CELSR1 | 1.35e-04 | 219 | 201 | 10 | IPR013320 |
| Domain | Cadherin_C | 1.38e-04 | 25 | 201 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.38e-04 | 25 | 201 | 4 | IPR000233 | |
| Domain | Catenin_binding_dom | 2.50e-04 | 29 | 201 | 4 | IPR027397 | |
| Domain | - | 2.50e-04 | 29 | 201 | 4 | 4.10.900.10 | |
| Domain | Growth_fac_rcpt_ | 2.92e-04 | 156 | 201 | 8 | IPR009030 | |
| Domain | PHOSPHORYLASE | 3.43e-04 | 3 | 201 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 3.43e-04 | 3 | 201 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 3.43e-04 | 3 | 201 | 2 | IPR000811 | |
| Domain | Phosphorylase | 3.43e-04 | 3 | 201 | 2 | PF00343 | |
| Domain | Laminin_G | 3.96e-04 | 58 | 201 | 5 | IPR001791 | |
| Domain | Dynein_HC_stalk | 4.10e-04 | 14 | 201 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.10e-04 | 14 | 201 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.10e-04 | 14 | 201 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.10e-04 | 14 | 201 | 3 | IPR011704 | |
| Domain | MT | 4.10e-04 | 14 | 201 | 3 | PF12777 | |
| Domain | AAA_5 | 4.10e-04 | 14 | 201 | 3 | PF07728 | |
| Domain | PROTEIN_KINASE_ATP | EPHB2 ERBB3 RIPK2 LMTK3 PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 EGFR CSK EPHA1 MAP3K2 | 4.68e-04 | 459 | 201 | 14 | PS00107 |
| Domain | DHC_fam | 5.08e-04 | 15 | 201 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.08e-04 | 15 | 201 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.08e-04 | 15 | 201 | 3 | IPR004273 | |
| Domain | CBS | 6.20e-04 | 16 | 201 | 3 | SM00116 | |
| Domain | Tensin_PTB | 6.82e-04 | 4 | 201 | 2 | IPR033929 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 6.82e-04 | 4 | 201 | 2 | IPR016245 | |
| Domain | LAM_G_DOMAIN | 7.22e-04 | 38 | 201 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 8.79e-04 | 40 | 201 | 4 | PF02210 | |
| Domain | PROTEIN_KINASE_DOM | EPHB2 ERBB3 RIPK2 LMTK3 PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 EGFR CSK EPHA1 MAP3K2 | 9.38e-04 | 493 | 201 | 14 | PS50011 |
| Domain | AAA | 9.56e-04 | 144 | 201 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 9.56e-04 | 144 | 201 | 7 | IPR003593 | |
| Domain | DMAP_binding | 1.13e-03 | 5 | 201 | 2 | PF06464 | |
| Domain | Cadherin_CS | 1.17e-03 | 109 | 201 | 6 | IPR020894 | |
| Domain | CBS_dom | 1.22e-03 | 20 | 201 | 3 | IPR000644 | |
| Domain | CBS | 1.22e-03 | 20 | 201 | 3 | PF00571 | |
| Domain | CBS | 1.22e-03 | 20 | 201 | 3 | PS51371 | |
| Domain | LamG | 1.26e-03 | 44 | 201 | 4 | SM00282 | |
| Domain | CADHERIN_1 | 1.40e-03 | 113 | 201 | 6 | PS00232 | |
| Domain | Cadherin | 1.40e-03 | 113 | 201 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.47e-03 | 114 | 201 | 6 | PS50268 | |
| Domain | - | 1.47e-03 | 114 | 201 | 6 | 2.60.40.60 | |
| Domain | CA | 1.54e-03 | 115 | 201 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.60e-03 | 116 | 201 | 6 | IPR015919 | |
| Domain | GF_recep_IV | 1.68e-03 | 6 | 201 | 2 | PF14843 | |
| Domain | DMAP1-bd | 1.68e-03 | 6 | 201 | 2 | IPR010506 | |
| Domain | GF_recep_IV | 1.68e-03 | 6 | 201 | 2 | IPR032778 | |
| Domain | DMAP_binding | 1.68e-03 | 6 | 201 | 2 | SM01137 | |
| Domain | Cadherin | 1.75e-03 | 118 | 201 | 6 | IPR002126 | |
| Domain | Kinase-like_dom | EPHB2 ERBB3 RIPK2 PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 ARHGAP35 EGFR CSK EPHA1 MAP3K2 | 2.27e-03 | 542 | 201 | 14 | IPR011009 |
| Domain | Recep_L_domain | 2.34e-03 | 7 | 201 | 2 | PF01030 | |
| Domain | Furin-like | 2.34e-03 | 7 | 201 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.34e-03 | 7 | 201 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 2.34e-03 | 7 | 201 | 2 | IPR006211 | |
| Domain | - | 2.34e-03 | 7 | 201 | 2 | 3.80.20.20 | |
| Domain | IPK | 2.34e-03 | 7 | 201 | 2 | PF03770 | |
| Domain | IPK | 2.34e-03 | 7 | 201 | 2 | IPR005522 | |
| Domain | Prot_kinase_dom | EPHB2 ERBB3 RIPK2 PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 EGFR CSK EPHA1 MAP3K2 | 2.53e-03 | 489 | 201 | 13 | IPR000719 |
| Domain | - | 2.66e-03 | 26 | 201 | 3 | 1.25.40.90 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 PTK2 MAP3K5 CDKL5 MET BRSK2 CILK1 EGFR CSK EPHA1 MAP3K2 | 2.76e-03 | 379 | 201 | 11 | IPR017441 |
| Domain | HECT | 2.97e-03 | 27 | 201 | 3 | PF00632 | |
| Domain | HECTc | 2.97e-03 | 27 | 201 | 3 | SM00119 | |
| Domain | HECT_dom | 2.97e-03 | 27 | 201 | 3 | IPR000569 | |
| Domain | HECT | 2.97e-03 | 27 | 201 | 3 | PS50237 | |
| Domain | PTEN_C2 | 3.09e-03 | 8 | 201 | 2 | PF10409 | |
| Domain | PTB | 3.09e-03 | 8 | 201 | 2 | IPR013625 | |
| Domain | DHC_N1 | 3.09e-03 | 8 | 201 | 2 | PF08385 | |
| Domain | PTEN_C2 | 3.09e-03 | 8 | 201 | 2 | SM01326 | |
| Domain | PTB | 3.09e-03 | 8 | 201 | 2 | PF08416 | |
| Domain | C2_TENSIN | 3.09e-03 | 8 | 201 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 3.09e-03 | 8 | 201 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 3.09e-03 | 8 | 201 | 2 | IPR014020 | |
| Domain | Dynein_heavy_dom-1 | 3.09e-03 | 8 | 201 | 2 | IPR013594 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ABAT ATG2A ACE ADRA1A SCN1A SCN2A SCN3A SCN9A DLG2 DAGLA ALPI DNMT1 KMO GRIP1 EGFR CTTN | 1.85e-06 | 367 | 150 | 16 | M48346 |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 5.64e-06 | 121 | 150 | 9 | M39823 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.45e-05 | 121 | 150 | 8 | M872 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 8.27e-05 | 98 | 150 | 7 | M39830 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 ACAT1 PDHB ZNF185 NKRF PTK2 PHGDH STAT1 UBA1 MDN1 PYGB PYGL UTP20 SCFD1 HERC2 ASCC3 BAG6 IMMT VARS1 GNL3 TNS3 DNMT1 FLNC COL8A1 RB1 RPAP3 POLD2 CAPZB PRPF8 PAPSS2 TGM3 GTF2I TOP2A | 3.52e-12 | 1353 | 203 | 33 | 29467282 |
| Pubmed | 6.45e-12 | 5 | 203 | 5 | 8812438 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP ACAT1 PDHB NCLN CMYA5 PHGDH STAT1 UBA1 MDN1 UTP20 SCFD1 GNAS BAG6 IMMT VARS1 GNL3 DNMT1 DNHD1 CHERP ATP13A1 CAPZB PPAT ECPAS PRPF8 TGM3 GTF2I SMARCE1 CTTN ATP1B3 TOP2A CPSF7 | 2.90e-10 | 1425 | 203 | 31 | 30948266 |
| Pubmed | USP34 ACAT1 CHD3 CCNK NKRF STAT1 UBA1 MDN1 EHMT2 PYGB PYGL IMMT GNL3 DNMT1 RB1 MED16 POLD2 ECPAS PRPF8 CCNA2 GTF2I SMARCE1 CTTN TOP2A CPSF7 | 1.51e-09 | 1014 | 203 | 25 | 32416067 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACAT1 CHD3 NCLN NKRF PHGDH STAT1 SCAF4 UBA1 MDN1 UTP20 GNAS HERC2 ASCC3 BAG6 IMMT VARS1 GNL3 FLNC CHERP NEDD4L CAPZB PRPF8 CTTN TOP2A CPSF7 | 1.84e-09 | 1024 | 203 | 25 | 24711643 |
| Pubmed | LGALS9C ACAT1 LGALS9B PDHB PHGDH UBA1 MDN1 PYGL SCFD1 GNAS ASCC3 IMMT GNL3 FLNC PRPF8 ATP1B3 TOP2A | 4.63e-09 | 484 | 203 | 17 | 31995728 | |
| Pubmed | SYNRG BCOR CCNK NKRF PHGDH STAT1 SCAF4 UBA1 RPRD2 ASCC3 DNMT1 RPAP3 CAPZB ARHGAP35 GTF2I SMARCE1 CTTN TOP2A | 4.68e-09 | 549 | 203 | 18 | 38280479 | |
| Pubmed | 5.61e-09 | 5 | 203 | 4 | 1679748 | ||
| Pubmed | 7.99e-09 | 13 | 203 | 5 | 15123669 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.67e-08 | 6 | 203 | 4 | 23652591 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 ERBB3 PDHB GCNT2 NCLN TRIP10 PTGS1 FAT1 SCFD1 GNAS BAG6 IMMT VARS1 PIGO MOCS1 FLNC CHERP ATP13A1 H6PD PRPF8 P3H4 TGM3 EGFR ASXL3 OXNAD1 SMARCE1 CTTN CPSF7 | 3.03e-08 | 1451 | 203 | 28 | 30550785 |
| Pubmed | USP34 ACAT1 NKRF MDN1 PYGB PYGL UTP20 HERC2 ASCC3 IMMT GNL3 DNMT1 FLNC CHERP ECPAS PRPF8 TGM3 GTF2I | 6.55e-08 | 653 | 203 | 18 | 22586326 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 ABCF3 PDHB ZNF185 TRIP10 PHGDH STAT1 UBA1 PYGB PYGL SCFD1 GNAS IMMT VARS1 TNS3 DNMT1 FLNC CAPZB ECPAS PRPF8 TGM3 SMARCE1 CTTN ATP1B3 TOP2A CPSF7 | 1.31e-07 | 1367 | 203 | 26 | 32687490 |
| Pubmed | 1.39e-07 | 9 | 203 | 4 | 16382098 | ||
| Pubmed | ABCF3 ACAT1 PDHB ITGA5 NCLN PTGS1 PHGDH MET ECEL1 IMMT VARS1 CAPZB H6PD PRPF8 GTF2I MEGF8 EGFR | 1.42e-07 | 613 | 203 | 17 | 22268729 | |
| Pubmed | 1.49e-07 | 234 | 203 | 11 | 36243803 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG CHD3 BCOR CCNK SCAF4 UBA1 MDN1 UTP20 SCFD1 BAG6 ALPI DNMT1 DIP2B ARHGAP35 ECPAS GTF2I EGFR CTTN TOP2A | 1.68e-07 | 774 | 203 | 19 | 15302935 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 USP34 MOSPD2 ITGA5 NCLN PTGS1 MET FAT1 UBA1 UTP20 ECEL1 PIGO DNMT1 NEDD4L LAMA4 H6PD BTN2A1 P3H4 TGFB2 CELSR1 MEGF8 EGFR SMARCE1 ATP1B3 | 1.71e-07 | 1201 | 203 | 24 | 35696571 |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 10995570 | ||
| Pubmed | β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. | 1.96e-07 | 3 | 203 | 3 | 21937717 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 12610651 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 18784617 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 19284629 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 33895391 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 23859570 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 25831463 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 17544618 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 21918175 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 14973256 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RIPK2 NCLN NEB SCAF4 MDN1 SCN9A ASCC3 BAG6 DPYD ECPAS PRPF8 KMO CTTN CDH7 CPSF7 | 2.72e-07 | 497 | 203 | 15 | 36774506 |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 3.12e-07 | 25 | 203 | 5 | 15254900 | |
| Pubmed | 3.87e-07 | 78 | 203 | 7 | 17192257 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 USP34 SCRT1 ABR PDHB RIPK2 CCNK PTK2 MET TNS3 MED16 BRSK2 TNS2 CCNA2 TGM3 EGFR CSK RTL1 CTTN MAP3K2 | 4.51e-07 | 910 | 203 | 20 | 36736316 |
| Pubmed | 5.38e-07 | 12 | 203 | 4 | 22102170 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ABR ACAT1 PDHB BCOR NKRF SCAF4 GNAS HERC2 BAG6 DNMT1 VPS37A CHERP AKIRIN2 PRPF8 TMEM263 GRIP1 GTF2I WDCP CTTN CPSF7 | 5.53e-07 | 922 | 203 | 20 | 27609421 |
| Pubmed | MAML1 CHD3 BCOR CCNK EHMT2 RPRD2 CHERP MED16 AR SMARCE1 CPSF7 | 5.77e-07 | 268 | 203 | 11 | 33640491 | |
| Pubmed | 5.94e-07 | 83 | 203 | 7 | 11114734 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG CHD3 BCOR CCNK NKRF PHGDH STAT1 SCAF4 UBA1 RPRD2 GNL3 DNMT1 CHERP RPAP3 ARHGAP35 PRPF8 GTF2I SMARCE1 CTTN TOP2A | 6.75e-07 | 934 | 203 | 20 | 33916271 |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 17452457 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 17537961 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 35801810 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 35031483 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 29578003 | ||
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 22733437 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 7.80e-07 | 4 | 203 | 3 | 8974318 | |
| Pubmed | Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. | 7.80e-07 | 4 | 203 | 3 | 15140944 | |
| Pubmed | 7.80e-07 | 4 | 203 | 3 | 17652939 | ||
| Pubmed | MAML1 BCOR CCNK SCAF4 SALL2 RPRD2 GNL3 DNMT1 RB1 PRPF8 GTF2I SMARCE1 | 8.44e-07 | 339 | 203 | 12 | 30415952 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | LGALS9C ACAT1 LGALS9B PDHB CCNK PHGDH STAT1 UBA1 ASCC3 IMMT DNMT1 DIP2B MED16 POLD2 CSK TRIM56 TOP2A | 9.10e-07 | 701 | 203 | 17 | 30196744 |
| Pubmed | PDHB NKRF PHGDH UBA1 MDN1 SCFD1 ASCC3 BAG6 IMMT VARS1 GNL3 CHERP ECPAS PRPF8 GTF2I CPSF7 | 1.25e-06 | 638 | 203 | 16 | 33239621 | |
| Pubmed | 1.94e-06 | 5 | 203 | 3 | 24337656 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACAT1 PDHB BCOR UBA1 PYGL SCFD1 GNAS BAG6 VARS1 GNL3 DNMT1 CAPZB PRPF8 SMARCE1 CTTN TOP2A | 2.13e-06 | 665 | 203 | 16 | 30457570 |
| Pubmed | ERBB3 PTK2 STAT1 MAP3K5 MET GNAS LAMA4 AR TGFB2 EGFR CTTN EPAS1 | 2.15e-06 | 371 | 203 | 12 | 25241761 | |
| Pubmed | MAML1 CHD3 BCOR CCNK PHGDH STAT1 SCAF4 UBA1 PYGL BAG6 VARS1 DNMT1 MED16 CAPZB PPAT ECPAS KHDC4 GTF2I SMARCE1 TOP2A CPSF7 | 2.27e-06 | 1103 | 203 | 21 | 34189442 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SYNRG ABCF3 ZNF185 BCOR STAT1 UBA1 SALL2 FLNC VPS37A RPAP3 GTF2I CTTN TOP2A | 2.42e-06 | 444 | 203 | 13 | 34795231 |
| Pubmed | ABAT SCRT1 ADGRV1 PTGS1 ADRA1A MLC1 SCN1A GNAS COL19A1 GRIP1 EGFR TOP2A | 2.47e-06 | 376 | 203 | 12 | 24154525 | |
| Pubmed | 3.59e-06 | 40 | 203 | 5 | 30898150 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.69e-06 | 154 | 203 | 8 | 16055720 | |
| Pubmed | MON2 SYNRG ABAT ACAT1 PDHB NCLN PHGDH CDKL5 MET UBA1 SCN1A PYGB DLG2 ACTL6B VARS1 NEDD4L ATP13A1 BRSK2 ARHGAP35 CRYBG3 CTTN | 3.73e-06 | 1139 | 203 | 21 | 36417873 | |
| Pubmed | NKRF PHGDH STAT1 GNAS ASCC3 GNL3 CHERP RPAP3 CAPZB PRPF8 P3H4 SMARCE1 CTTN TOP2A CPSF7 | 3.80e-06 | 615 | 203 | 15 | 31048545 | |
| Pubmed | Yeast two-hybrid screening for proteins that interact with alpha1-adrenergic receptors. | 3.87e-06 | 6 | 203 | 3 | 15525470 | |
| Pubmed | 3.87e-06 | 6 | 203 | 3 | 28077433 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | CHD3 UBA1 MDN1 VARS1 DNMT1 MPI DIP2B PRPF8 GTF2I TOP2A CPSF7 | 4.59e-06 | 332 | 203 | 11 | 32786267 |
| Pubmed | ABR CCNK PHGDH STAT1 UBA1 ASCC3 IMMT RPAP3 CAPZB ECPAS GRIP1 EGFR CSK CRYBG3 CTTN ATP1B3 | 4.72e-06 | 708 | 203 | 16 | 39231216 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 USP34 PDHB NCLN PYGL GNAS ASCC3 BAG6 IMMT VARS1 TNS3 DIP2B FLNC TNS2 ECPAS PRPF8 GTF2I CSK CTTN | 5.01e-06 | 974 | 203 | 19 | 28675297 |
| Pubmed | MOSPD2 ABCF3 ABR NCLN MDN1 PYGB GNAS HERC2 ASCC3 BAG6 IMMT PIGO GNL3 DIP2B CHERP MED16 ATP13A1 ECPAS PRPF8 GTF2I CPSF7 | 5.48e-06 | 1168 | 203 | 21 | 19946888 | |
| Pubmed | PDHB NCLN PHGDH SCFD1 BAG6 IMMT GNL3 FLNC ECPAS PRPF8 CCNA2 ATP1B3 | 5.68e-06 | 408 | 203 | 12 | 33766124 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | LGALS9C LGALS9B ITGA5 ITGB3 PHGDH UBA1 MDN1 VARS1 DIP2B FLNC PRPF8 | 6.42e-06 | 344 | 203 | 11 | 30333137 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.43e-06 | 220 | 203 | 9 | 35785414 | |
| Pubmed | Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions. | 6.74e-06 | 7 | 203 | 3 | 22493501 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABAT ABR TSHZ2 DGKH CHD3 ADGRV1 PTK2 RPRD2 GNAS DAGLA GNL3 ZNF449 ENOSF1 DIP2B VPS37A NEDD4L CILK1 H6PD ARHGAP35 ECPAS AR GTF2I EGFR SETBP1 | 7.21e-06 | 1489 | 203 | 24 | 28611215 |
| Pubmed | USP34 CHD3 BCOR SALL2 EHMT2 ASCC3 RPAP3 ECPAS TXNIP GTF2I WDCP CRYBG3 | 7.25e-06 | 418 | 203 | 12 | 34709266 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DGKH ZNF831 PTGS1 FOCAD ADRA1A MDN1 CDH20 HECW2 SCN3A UTP20 COL8A1 RB1 DNAH2 ECPAS PRPF8 FRY | 7.66e-06 | 736 | 203 | 16 | 29676528 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ABAT STAT1 PYGL DIP2B NEDD4L ARHGAP35 ECPAS PRPF8 GRIP1 CSK CTTN TOP2A CPSF7 | 8.34e-06 | 498 | 203 | 13 | 36634849 |
| Pubmed | MON2 USP34 ABCA12 CHD3 BCOR NKRF FAT1 SALL2 CLCNKA EHMT2 ACTL6B ASCC3 GNL3 RB1 NTAQ1 P3H4 TRIM56 SMARCE1 CRYBG3 TOP2A | 9.73e-06 | 1116 | 203 | 20 | 31753913 | |
| Pubmed | CCNK STAT1 SCAF4 UBA1 RPRD2 CHERP CAPZB ARHGAP35 TGFB2 GTF2I SMARCE1 CTTN CPSF7 | 9.87e-06 | 506 | 203 | 13 | 30890647 | |
| Pubmed | ACAT1 PDHB ZNF185 CHD3 PHGDH CDKL5 UBA1 HECW2 SCN2A PYGB DLG2 ACTL6B DAGLA IMMT VARS1 FLNC NEDD4L CAPZB BRSK2 ARHGAP35 CTTN CPSF7 DNAH11 | 1.19e-05 | 1431 | 203 | 23 | 37142655 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.20e-05 | 130 | 203 | 7 | 35545047 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG CEP85L ZNF185 MAML1 ATG2A ACE HERC2 GNL3 RPAP3 CAPZB CILK1 ECPAS GRIP1 TGM3 WDCP CTTN TOP2A | 1.22e-05 | 853 | 203 | 17 | 28718761 |
| Pubmed | USP34 KIFBP ACAT1 PDHB CHD3 BCOR PHGDH UBA1 SCFD1 GNAS ASCC3 IMMT GNL3 RPAP3 POLD2 CAPZB PPAT PRPF8 GTF2I SMARCE1 CTTN ATP1B3 | 1.27e-05 | 1335 | 203 | 22 | 29229926 | |
| Pubmed | ACAT1 NCLN PHGDH STAT1 EHMT2 PYGL ASCC3 GNL3 DNMT1 PRPF8 PAPSS2 TXNIP TRIM56 TOP2A | 1.35e-05 | 601 | 203 | 14 | 33658012 | |
| Pubmed | 1.46e-05 | 134 | 203 | 7 | 24658140 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PDHB PHGDH SCAF4 UBA1 SALL2 MDN1 PYGL SCFD1 GNAS ASCC3 BAG6 VARS1 GNL3 FLNC CAPZB ECPAS PRPF8 GTF2I CTTN CPSF7 | 1.48e-05 | 1149 | 203 | 20 | 35446349 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ACAT1 PDHB UBA1 PYGB PYGL IMMT VARS1 CHERP PPAT ECPAS PRPF8 CTTN TOP2A CPSF7 | 1.50e-05 | 607 | 203 | 14 | 39147351 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 USP34 KIFBP ABCF3 PDHB CMYA5 TRIP10 STAT1 PARP6 UBA1 PYGB PYGL BAG6 VARS1 TNS3 FLNC POLD2 CAPZB PPAT ECPAS PAPSS2 GTF2I CTTN | 1.54e-05 | 1455 | 203 | 23 | 22863883 |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 23866081 | ||
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 1.60e-05 | 9 | 203 | 3 | 23115349 | |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 15746173 | ||
| Pubmed | Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. | 1.60e-05 | 9 | 203 | 3 | 23640055 | |
| Pubmed | 1.60e-05 | 9 | 203 | 3 | 21670307 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | NEB PTK2 CDKL5 HERC2 BAG6 VARS1 GNL3 CHERP RB1 MED16 CILK1 PRPF8 CCNA2 FRY WDCP | 1.61e-05 | 695 | 203 | 15 | 23602568 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 PDHB NCLN NKRF PHGDH STAT1 UBA1 MDN1 PYGB PYGL GNAS ASCC3 BAG6 IMMT VARS1 GNL3 POLD2 PPAT PRPF8 GTF2I CPSF7 | 1.65e-05 | 1257 | 203 | 21 | 37317656 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.71e-05 | 313 | 203 | 10 | 38270169 | |
| Pubmed | 1.77e-05 | 55 | 203 | 5 | 27114453 | ||
| Pubmed | PDHB NCLN PHGDH STAT1 UBA1 SCN2A PYGB GNAS IMMT VARS1 CAPZB PRPF8 TMEM263 OXNAD1 TOP2A MAP3K2 | 2.22e-05 | 803 | 203 | 16 | 36517590 | |
| Pubmed | 2.24e-05 | 323 | 203 | 10 | 24797263 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KIFBP ACAT1 RIPK2 CMYA5 PTK2 STAT1 MET GNAS HERC2 BAG6 VARS1 GNL3 ALPI CAPZB ECPAS PRPF8 PAPSS2 GTF2I WDCP ATP1B3 MAP3K2 | 2.26e-05 | 1284 | 203 | 21 | 17353931 |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 2.28e-05 | 10 | 203 | 3 | 11435397 | |
| Pubmed | 2.36e-05 | 259 | 203 | 9 | 31162944 | ||
| Pubmed | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. | 2.39e-05 | 29 | 203 | 4 | 21909115 | |
| Interaction | TNS1 interactions | 1.60e-07 | 41 | 203 | 7 | int:TNS1 | |
| Interaction | SCN9A interactions | 1.76e-06 | 21 | 203 | 5 | int:SCN9A | |
| Interaction | LGALS9 interactions | LGALS9C ACAT1 LGALS9B PDHB ITGA5 PHGDH MET UBA1 MDN1 PYGL SCFD1 GNAS ASCC3 IMMT GNL3 FLNC LAMA4 PRPF8 ATP1B3 TOP2A | 2.22e-06 | 588 | 203 | 20 | int:LGALS9 |
| Interaction | SIRT6 interactions | ABCF3 CHD3 BCOR TRIP10 NKRF FAT1 EHMT2 RPRD2 HERC2 ASCC3 BAG6 MED16 POLD2 CAPZB PRPF8 CELSR1 GTF2I WDCP CTTN TOP2A | 5.96e-06 | 628 | 203 | 20 | int:SIRT6 |
| Interaction | STAP1 interactions | 6.65e-06 | 27 | 203 | 5 | int:STAP1 | |
| Interaction | ZBTB7A interactions | 7.33e-06 | 131 | 203 | 9 | int:ZBTB7A | |
| Interaction | ITGB3 interactions | 9.04e-06 | 170 | 203 | 10 | int:ITGB3 | |
| Interaction | STIP1 interactions | PDHB NEB NKRF PTK2 PHGDH UBA1 MDN1 SCFD1 ASCC3 BAG6 IMMT VARS1 GNL3 TNS3 CHERP RPAP3 CAPZB ECPAS PRPF8 WDFY4 AR TXNIP GTF2I EGFR CSK CPSF7 | 1.01e-05 | 1006 | 203 | 26 | int:STIP1 |
| Interaction | SH2D2A interactions | 1.34e-05 | 52 | 203 | 6 | int:SH2D2A | |
| Interaction | SH2D1B interactions | 1.59e-05 | 32 | 203 | 5 | int:SH2D1B | |
| Interaction | WWTR1 interactions | SYNRG BCOR STAT1 UBA1 RPRD2 ASCC3 DNMT1 RB1 RPAP3 CAPZB GTF2I TLE6 SMARCE1 TOP2A MAP3K2 | 2.62e-05 | 422 | 203 | 15 | int:WWTR1 |
| Interaction | TNS3 interactions | 2.80e-05 | 87 | 203 | 7 | int:TNS3 | |
| Interaction | EP300 interactions | ABCF3 MAML1 CHD3 NCLN NKRF PHGDH STAT1 MAP3K5 SCAF4 EHMT2 BAG6 IMMT VARS1 GNL3 DNMT1 RB1 RPAP3 POLD2 ECPAS PRPF8 AR CCNA2 GRIP1 GTF2I EGFR TLE6 SMARCE1 CTTN TOP2A EPAS1 CPSF7 | 2.89e-05 | 1401 | 203 | 31 | int:EP300 |
| Interaction | CDC37 interactions | EPHB2 ERBB3 ACAT1 LMTK3 PTK2 CDKL5 MET IMMT RPAP3 CAPZB CILK1 TNS2 PRPF8 AR EGFR CSK CTTN TOP2A EPHA1 | 3.02e-05 | 645 | 203 | 19 | int:CDC37 |
| Interaction | PLA2G2A interactions | 3.78e-05 | 38 | 203 | 5 | int:PLA2G2A | |
| Interaction | YAP1 interactions | PDHB CCNK NKRF PHGDH STAT1 SCAF4 UBA1 HECW2 SCN1A RPRD2 GNAS IMMT DNMT1 NEDD4L RB1 RPAP3 CAPZB ARHGAP35 PRPF8 AR GTF2I EGFR SMARCE1 CTTN MAP3K2 CPSF7 | 4.30e-05 | 1095 | 203 | 26 | int:YAP1 |
| Interaction | TMA16 interactions | 4.96e-05 | 95 | 203 | 7 | int:TMA16 | |
| Interaction | BAIAP2L1 interactions | 4.97e-05 | 129 | 203 | 8 | int:BAIAP2L1 | |
| Interaction | RASA1 interactions | 5.08e-05 | 167 | 203 | 9 | int:RASA1 | |
| Interaction | MED14 interactions | 6.10e-05 | 171 | 203 | 9 | int:MED14 | |
| Interaction | SHC4 interactions | 6.34e-05 | 22 | 203 | 4 | int:SHC4 | |
| Interaction | AR interactions | USP34 MAML1 CHD3 BCOR CCNK PHGDH MDN1 EHMT2 RPRD2 GNAS BAG6 GNL3 CHERP RB1 MED16 CAPZB ECPAS PRPF8 AR GRIP1 GTF2I EGFR SMARCE1 CPSF7 | 6.48e-05 | 992 | 203 | 24 | int:AR |
| Interaction | SIRT7 interactions | USP34 ACAT1 NKRF MDN1 PYGB PYGL UTP20 HERC2 ASCC3 IMMT GNL3 DNMT1 FLNC CHERP RB1 ECPAS PRPF8 TGM3 GTF2I TOP2A | 6.67e-05 | 744 | 203 | 20 | int:SIRT7 |
| Interaction | CTBP1 interactions | MAML1 CHD3 GCNT2 BCOR EHMT2 ACTL6B BAG6 DNMT1 RB1 NTAQ1 AR EGFR WDCP CPSF7 | 6.76e-05 | 406 | 203 | 14 | int:CTBP1 |
| Interaction | MATK interactions | 6.96e-05 | 43 | 203 | 5 | int:MATK | |
| Interaction | MED10 interactions | 7.81e-05 | 102 | 203 | 7 | int:MED10 | |
| Interaction | GABRA2 interactions | 8.09e-05 | 9 | 203 | 3 | int:GABRA2 | |
| Interaction | SH2D1A interactions | 8.69e-05 | 45 | 203 | 5 | int:SH2D1A | |
| Interaction | SOCS5 interactions | 9.07e-05 | 24 | 203 | 4 | int:SOCS5 | |
| Interaction | FAM66E interactions | 1.01e-04 | 2 | 203 | 2 | int:FAM66E | |
| Interaction | IL6ST interactions | 1.02e-04 | 74 | 203 | 6 | int:IL6ST | |
| Interaction | ABL2 interactions | 1.06e-04 | 107 | 203 | 7 | int:ABL2 | |
| Interaction | SH2B3 interactions | 1.07e-04 | 25 | 203 | 4 | int:SH2B3 | |
| Interaction | HSH2D interactions | 1.07e-04 | 25 | 203 | 4 | int:HSH2D | |
| Interaction | GBE1 interactions | 1.10e-04 | 75 | 203 | 6 | int:GBE1 | |
| Interaction | PTPN12 interactions | 1.13e-04 | 145 | 203 | 8 | int:PTPN12 | |
| Interaction | MS4A10 interactions | 1.15e-04 | 10 | 203 | 3 | int:MS4A10 | |
| Interaction | ANGPTL3 interactions | 1.15e-04 | 10 | 203 | 3 | int:ANGPTL3 | |
| Interaction | RHOB interactions | EPHB2 ABR ACAT1 PDHB DGKH ITGA5 NCLN PHGDH FAT1 UBA1 MDN1 UTP20 SCFD1 GNAS IMMT DIP2B NEDD4L BRSK2 ARHGAP35 EGFR ATP1B3 | 1.21e-04 | 840 | 203 | 21 | int:RHOB |
| Interaction | WWP2 interactions | LGALS9B TRIP10 NKRF PHGDH STAT1 GNAS ASCC3 BAG6 GNL3 CHERP RPAP3 SFTPC CAPZB PRPF8 P3H4 TXNIP TGM3 SMARCE1 CTTN TOP2A CPSF7 | 1.21e-04 | 840 | 203 | 21 | int:WWP2 |
| Interaction | FBXO6 interactions | ABCF3 ACAT1 PDHB ITGA5 NCLN PTGS1 PHGDH MET ECEL1 IMMT VARS1 CAPZB H6PD PRPF8 TGFB2 GTF2I MEGF8 EGFR GALNT6 | 1.23e-04 | 717 | 203 | 19 | int:FBXO6 |
| Interaction | PLPPR3 interactions | 1.26e-04 | 26 | 203 | 4 | int:PLPPR3 | |
| Interaction | TNS2 interactions | 1.41e-04 | 235 | 203 | 10 | int:TNS2 | |
| Interaction | HCK interactions | 1.54e-04 | 193 | 203 | 9 | int:HCK | |
| Interaction | CLMP interactions | 1.57e-04 | 11 | 203 | 3 | int:CLMP | |
| Interaction | DUSP2 interactions | 1.68e-04 | 81 | 203 | 6 | int:DUSP2 | |
| Interaction | FNDC5 interactions | USP34 ERBB3 PDHB ZNF185 GCNT2 NCLN TRIP10 PTGS1 FAT1 SCFD1 ALDH3A1 GNAS BAG6 IMMT VARS1 PIGO MOCS1 FLNC CHERP ATP13A1 H6PD PRPF8 P3H4 TGM3 EGFR ASXL3 OXNAD1 SMARCE1 CTTN CPSF7 | 1.69e-04 | 1470 | 203 | 30 | int:FNDC5 |
| Interaction | BIRC3 interactions | ACAT1 PDHB RIPK2 NCLN CMYA5 PHGDH UBA1 MDN1 UTP20 GNAS BAG6 IMMT VARS1 GNL3 DNMT1 DNHD1 CHERP ATP13A1 CAPZB PRPF8 TGM3 GTF2I EGFR SMARCE1 CTTN ATP1B3 TOP2A CPSF7 | 1.79e-04 | 1334 | 203 | 28 | int:BIRC3 |
| Interaction | BTNL2 interactions | 1.79e-04 | 155 | 203 | 8 | int:BTNL2 | |
| Interaction | PRMT1 interactions | PDHB NKRF PHGDH STAT1 MAP3K5 UBA1 GNL3 FLNC CHERP NTAQ1 CAPZB TNS2 PPAT PRPF8 AR GRIP1 GTF2I EGFR ASXL3 CTTN IGSF21 CPSF7 | 1.80e-04 | 929 | 203 | 22 | int:PRMT1 |
| Interaction | GSK3B interactions | SYNRG CHD3 PTK2 PHGDH MET UBA1 HECW2 PYGL ACTL6B HERC2 ASCC3 BAG6 TNS3 DNMT1 ARHGAP35 AR CRYBG3 CTTN IGSF21 TOP2A MAP3K2 | 1.90e-04 | 868 | 203 | 21 | int:GSK3B |
| Interaction | PML interactions | USP34 SYNRG ABCF3 PDHB ZNF185 BCOR STAT1 MDN1 EHMT2 PYGB UTP20 MOCS1 FLNC VPS37A RB1 RPAP3 MED16 CDH19 GTF2I EGFR CTTN TOP2A | 1.91e-04 | 933 | 203 | 22 | int:PML |
| Interaction | PRAG1 interactions | 1.95e-04 | 29 | 203 | 4 | int:PRAG1 | |
| Interaction | SCN1A interactions | 1.95e-04 | 29 | 203 | 4 | int:SCN1A | |
| Interaction | ARRDC2 interactions | 2.09e-04 | 54 | 203 | 5 | int:ARRDC2 | |
| Interaction | PPP1R9B interactions | ABAT ACAT1 PDHB LMTK3 PHGDH MAP3K5 CDKL5 ADRA1A UBA1 PYGB DLG2 IMMT VARS1 RB1 CAPZB BRSK2 CTTN | 2.12e-04 | 626 | 203 | 17 | int:PPP1R9B |
| Interaction | VAV3 interactions | 2.28e-04 | 55 | 203 | 5 | int:VAV3 | |
| Interaction | SYK interactions | 2.41e-04 | 251 | 203 | 10 | int:SYK | |
| Interaction | CBX4 interactions | 2.41e-04 | 205 | 203 | 9 | int:CBX4 | |
| Interaction | CFD interactions | USP34 ERBB3 PDHB GCNT2 NCLN TRIP10 PTGS1 FAT1 SCFD1 GNAS BAG6 IMMT VARS1 PIGO MOCS1 FLNC CHERP ATP13A1 H6PD PRPF8 P3H4 TGM3 EGFR ASXL3 OXNAD1 SMARCE1 CTTN CPSF7 | 2.46e-04 | 1360 | 203 | 28 | int:CFD |
| Interaction | PPP1CA interactions | KIFBP PDHB CHD3 PTK2 CDKL5 PYGB PYGL RPRD2 HERC2 CHERP RB1 RPAP3 CAPZB PRPF8 WDFY4 AR WDCP TOP2A | 2.50e-04 | 696 | 203 | 18 | int:PPP1CA |
| Interaction | RNF123 interactions | DGKH ITGA5 ZNF831 PTGS1 FOCAD ADRA1A MDN1 CDH20 HECW2 SCN3A UTP20 BAG6 FLNC COL8A1 RB1 DNAH2 AKIRIN2 ECPAS PRPF8 FRY | 2.61e-04 | 824 | 203 | 20 | int:RNF123 |
| Interaction | EEF1A1 interactions | ACAT1 PDHB CHD3 PHGDH UBA1 PYGB HERC2 IMMT VARS1 DNMT1 CAPZB LAMA4 ECPAS PRPF8 TXNIP GTF2I EGFR ASXL3 CTTN | 2.67e-04 | 762 | 203 | 19 | int:EEF1A1 |
| Interaction | MECOM interactions | PDHB CHD3 NEB PHGDH EHMT2 BAG6 IMMT GNL3 FLNC CHERP GTF2I SMARCE1 | 2.90e-04 | 358 | 203 | 12 | int:MECOM |
| Interaction | SLITRK5 interactions | 3.18e-04 | 59 | 203 | 5 | int:SLITRK5 | |
| Interaction | GRIN2B interactions | 3.36e-04 | 170 | 203 | 8 | int:GRIN2B | |
| Interaction | RNASE4 interactions | 3.38e-04 | 14 | 203 | 3 | int:RNASE4 | |
| Interaction | EWSR1 interactions | ACAT1 MAML1 CHD3 ITGA5 ACE ITGB3 NKRF SALL2 BAG6 CHERP MED16 CAPZB KHDC4 GTF2I EGFR TLE6 SMARCE1 CTTN ATP1B3 EPAS1 CPSF7 | 3.38e-04 | 906 | 203 | 21 | int:EWSR1 |
| Interaction | SP1 interactions | NEB BCOR FAT1 UBA1 GNL3 DNMT1 NEDD4L RB1 CAPZB AR CCNA2 EPAS1 | 3.46e-04 | 365 | 203 | 12 | int:SP1 |
| Interaction | FGR interactions | 3.57e-04 | 93 | 203 | 6 | int:FGR | |
| Interaction | SH2D3C interactions | 3.63e-04 | 172 | 203 | 8 | int:SH2D3C | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.53e-07 | 9 | 134 | 4 | 1203 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.96e-06 | 13 | 134 | 4 | 1186 | |
| GeneFamily | Chloride voltage-gated channels | 4.60e-05 | 10 | 134 | 3 | 302 | |
| GeneFamily | Glycogen phosphorylases | 1.63e-04 | 3 | 134 | 2 | 437 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 3.24e-04 | 4 | 134 | 2 | 1096 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.48e-03 | 8 | 134 | 2 | 837 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.38e-03 | 36 | 134 | 3 | 823 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPR155 ABR TSHZ2 CEP85L CHD3 NEB PLPPR1 MDN1 CLCN4 SCN1A SCN2A SCN3A SCN9A DLG2 ACTL6B DIP2B COL8A1 NEDD4L BRSK2 ARHGAP35 GRIP1 FRY ASXL3 MAP3K2 | 5.05e-06 | 1106 | 202 | 24 | M39071 |
| Coexpression | PURWIN_MEWO_SOX10_TARGETS | 7.33e-06 | 92 | 202 | 7 | M48228 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | GPR155 TSHZ2 ADGRV1 PLPPR1 PHGDH MAP3K5 FAT1 SALL2 MLC1 SCN1A PYGL VWA3A FLNC COL8A1 P3H4 CELSR1 | 1.07e-05 | 574 | 202 | 16 | M39056 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.37e-05 | 184 | 202 | 9 | M19988 | |
| Coexpression | ALK_DN.V1_UP | 1.43e-05 | 141 | 202 | 8 | M2774 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 2.09e-05 | 194 | 202 | 9 | M8864 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | TRIP10 PTGS1 STAT1 PYGB PYGL DNMT1 DPYD LAMA4 CCNA2 CSK ATP1B3 TOP2A | 2.45e-05 | 359 | 202 | 12 | M15193 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN | 2.55e-05 | 199 | 202 | 9 | M7472 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_UP | 3.40e-05 | 159 | 202 | 8 | M10025 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 4.62e-05 | 166 | 202 | 8 | M344 | |
| Coexpression | CHIN_BREAST_CANCER_COPY_NUMBER_UP | 6.06e-05 | 28 | 202 | 4 | M672 | |
| Coexpression | PURWIN_A375_SOX10_TARGETS | 6.58e-05 | 55 | 202 | 5 | M48227 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | GPR155 ERBB3 MOSPD2 BCOR PTK2 CLCN4 DLG2 TNS3 DIP2B SFTPC CILK1 TNS2 CDH19 FRY PLA2G4C GALNT6 CTTN | 8.18e-05 | 754 | 202 | 17 | M39037 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NCLN PTK2 FOCAD MDN1 PYGL UTP20 VARS1 GNL3 DNMT1 NTAQ1 PPAT ECPAS P3H4 CCNA2 TOP2A | 8.71e-05 | 612 | 202 | 15 | M4772 |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 1.01e-04 | 294 | 202 | 10 | M1804 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | SLC43A2 ABAT ADGRV1 GCNT2 BCOR MET MDN1 DLG2 ENOSF1 DIP2B DNAH2 CFAP46 | 1.03e-04 | 417 | 202 | 12 | M39224 |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.07e-04 | 97 | 202 | 6 | M14698 | |
| Coexpression | KAYO_AGING_MUSCLE_UP | 1.16e-04 | 242 | 202 | 9 | M16050 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SLC43A2 ERBB3 ABR CHD3 ADGRV1 GCNT2 PTGS1 PHGDH MAP3K5 MET SCN9A DLG2 COL8A1 ADAMTSL1 NEDD4L RB1 SLC26A5 DNAH2 PAPSS2 TGFB2 GRIP1 CELSR1 EGFR TLE6 EPAS1 | 5.90e-06 | 984 | 199 | 25 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB3 ADGRV1 GCNT2 MET SLC26A8 ASCC3 NEDD4L AGR3 GRIP1 EYS CELSR1 | 5.74e-10 | 176 | 203 | 11 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ERBB3 ADGRV1 GCNT2 MET SCN9A ADAMTSL1 AGR3 AR GRIP1 FRY CELSR1 | 1.61e-09 | 194 | 203 | 11 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 NEB FAT1 SCN2A SCN9A OTOA COL19A1 ASXL3 DNAH11 | 1.35e-08 | 184 | 203 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 NEB FAT1 SCN2A SCN9A OTOA COL19A1 ASXL3 DNAH11 | 1.35e-08 | 184 | 203 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 ADGRV1 NEB FAT1 SCN2A SCN9A OTOA COL19A1 ASXL3 DNAH11 | 1.35e-08 | 184 | 203 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | ERBB3 ADGRV1 MET NEDD4L SFTPC AGR3 CELSR1 DUOXA1 EGFR DNAH11 | 1.66e-08 | 188 | 203 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.93e-08 | 191 | 203 | 10 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SLC43A2 CMYA5 PLPPR1 ENOSF1 NEDD4L STPG2 SLC3A1 GRIP1 CELSR1 TRPV4 | 2.13e-08 | 193 | 203 | 10 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ADGRV1 GCNT2 SCN1A DLG2 COL8A1 NEDD4L SFTPC AGR3 DUOXA1 EGFR | 2.24e-08 | 194 | 203 | 10 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ERBB3 ADGRV1 GCNT2 PLPPR1 SCN9A ADAMTSL1 AR GRIP1 FRY CELSR1 | 2.24e-08 | 194 | 203 | 10 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-08 | 199 | 203 | 10 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.13e-08 | 155 | 203 | 9 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.69e-08 | 169 | 203 | 9 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.35e-07 | 178 | 203 | 9 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | (00)_Basal-(0)_uninjured|(00)_Basal / shred by cell type and Timepoint | 1.63e-07 | 182 | 203 | 9 | c02c9cab4389d80f318f4bb8d703c1e719672624 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC43A2 ADGRV1 GCNT2 LMTK3 PLPPR1 CLCNKA CLCNKB NEDD4L STPG2 | 1.63e-07 | 182 | 203 | 9 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-07 | 185 | 203 | 9 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.06e-07 | 187 | 203 | 9 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.25e-07 | 189 | 203 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.57e-07 | 192 | 203 | 9 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.57e-07 | 192 | 203 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-07 | 194 | 203 | 9 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.81e-07 | 194 | 203 | 9 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-07 | 194 | 203 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-07 | 194 | 203 | 9 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.93e-07 | 195 | 203 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.06e-07 | 196 | 203 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.06e-07 | 196 | 203 | 9 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.06e-07 | 196 | 203 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.06e-07 | 196 | 203 | 9 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 197 | 203 | 9 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-07 | 197 | 203 | 9 | 1018aac22659c081d227d566afa29b1748c18ade | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-07 | 198 | 203 | 9 | a11ac83dbd69d1c068971266d7c7343d114a6294 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.33e-07 | 198 | 203 | 9 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 198 | 203 | 9 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 199 | 203 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 199 | 203 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-07 | 200 | 203 | 9 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-07 | 200 | 203 | 9 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.63e-07 | 200 | 203 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.63e-07 | 200 | 203 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.36e-07 | 165 | 203 | 8 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.36e-07 | 165 | 203 | 8 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 9.80e-07 | 166 | 203 | 8 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 1.23e-06 | 171 | 203 | 8 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.28e-06 | 172 | 203 | 8 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-06 | 173 | 203 | 8 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-06 | 176 | 203 | 8 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-06 | 177 | 203 | 8 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.80e-06 | 180 | 203 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-06 | 181 | 203 | 8 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.95e-06 | 182 | 203 | 8 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.95e-06 | 182 | 203 | 8 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.04e-06 | 183 | 203 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-06 | 184 | 203 | 8 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.21e-06 | 185 | 203 | 8 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 185 | 203 | 8 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.30e-06 | 186 | 203 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-06 | 186 | 203 | 8 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.39e-06 | 187 | 203 | 8 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-06 | 187 | 203 | 8 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.39e-06 | 187 | 203 | 8 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-06 | 187 | 203 | 8 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.49e-06 | 188 | 203 | 8 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.49e-06 | 188 | 203 | 8 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.49e-06 | 188 | 203 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 189 | 203 | 8 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 189 | 203 | 8 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.69e-06 | 190 | 203 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.69e-06 | 190 | 203 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-06 | 191 | 203 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-06 | 191 | 203 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.91e-06 | 192 | 203 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.91e-06 | 192 | 203 | 8 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 192 | 203 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.91e-06 | 192 | 203 | 8 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 192 | 203 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.91e-06 | 192 | 203 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 192 | 203 | 8 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 3.02e-06 | 193 | 203 | 8 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.02e-06 | 193 | 203 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 193 | 203 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-06 | 193 | 203 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 193 | 203 | 8 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-06 | 193 | 203 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.02e-06 | 193 | 203 | 8 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.02e-06 | 193 | 203 | 8 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-06 | 193 | 203 | 8 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 3.02e-06 | 193 | 203 | 8 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.02e-06 | 193 | 203 | 8 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 193 | 203 | 8 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.14e-06 | 194 | 203 | 8 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.14e-06 | 194 | 203 | 8 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-06 | 195 | 203 | 8 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.65e-06 | 198 | 203 | 8 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|COVID-19 / Condition, Lineage and Cell class | 3.65e-06 | 198 | 203 | 8 | 7e6f089e71e70190ff8486341ab06719d7741467 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 198 | 203 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-06 | 198 | 203 | 8 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.65e-06 | 198 | 203 | 8 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-06 | 198 | 203 | 8 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| Drug | AC1L9JWW | 2.07e-08 | 21 | 200 | 6 | CID000446637 | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | GCNT2 PTGS1 NKRF SCAF4 BMP10 MOCS1 COL8A1 SFTPC MED16 TNS2 H6PD ARHGAP35 | 2.08e-07 | 199 | 200 | 12 | 6097_DN |
| Drug | AC1OAGFB | EPHB2 RIPK2 DGKH ITGB3 TRIP10 PTK2 SCN3A SCN9A ACTL6B GNAS DAGLA ALPI MPI CAPZB ARHGAP35 PLA2G4C EGFR CSK CTTN | 3.19e-07 | 539 | 200 | 19 | CID006857345 |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | EPHB2 MON2 GCNT2 PARP6 MET CLCN4 ALDH3A1 LAMA4 H6PD SLC3A1 MEGF8 | 1.51e-06 | 198 | 200 | 11 | 6388_DN |
| Drug | NaCl | ACE PTGS1 PTK2 CLCN4 CLCNKA CLCNKB MLC1 SCN2A ACTL6B GNL3 POLD2 LAMA4 CILK1 H6PD AR TGFB2 SLC9A5 ATP1B3 | 2.71e-06 | 564 | 200 | 18 | CID000005234 |
| Drug | creatinine | ABAT ACE NKRF PHGDH CLCNKA CLCNKB HPD GNAS ALPI DPYD RB1 TGFB2 EGFR | 2.94e-06 | 302 | 200 | 13 | CID000000588 |
| Drug | SU11274 | 3.43e-06 | 27 | 200 | 5 | CID009549297 | |
| Drug | tungstate | 5.12e-06 | 108 | 200 | 8 | CID000001152 | |
| Drug | indirubin-5-sulphonate | 6.59e-06 | 5 | 200 | 3 | CID005288641 | |
| Drug | AC1O3M08 | 6.59e-06 | 5 | 200 | 3 | CID006331955 | |
| Drug | 4-hydroxy-2-nonenal | HLX DGKH ITGA5 CCNK PTK2 PHGDH STAT1 UBA1 ALDH3A1 GNAS RB1 AOAH GPX2 CAPZB CILK1 H6PD CCNA2 TRPV4 CTTN ATP1B3 TOP2A | 7.95e-06 | 798 | 200 | 21 | ctd:C027576 |
| Drug | alpha-Chlorohydrin | SLC43A2 ABAT ABCF3 ABR ACAT1 AKR1D1 ACE PLPPR1 PTGS1 PHGDH CDKL5 SLC26A8 PYGB PYGL MOCS1 TNS3 NEDD4L PPAT PAPSS2 TXNIP EGFR TRPV4 MAP3K2 | 9.57e-06 | 941 | 200 | 23 | ctd:D000517 |
| Drug | L-adrenaline | ADGRV1 ITGA5 ACE ITGB3 PTGS1 ADRA1A CLCN4 CLCNKA CLCNKB PYGB PYGL GNAS AR TGFB2 ATP1B3 | 1.02e-05 | 446 | 200 | 15 | CID000000838 |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.06e-05 | 198 | 200 | 10 | 5006_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.16e-05 | 200 | 200 | 10 | 5991_UP | |
| Drug | Zonisamide | 1.26e-05 | 17 | 200 | 4 | DB00909 | |
| Drug | EdUMP | 1.31e-05 | 6 | 200 | 3 | CID003085112 | |
| Drug | anthranilic acid | 1.36e-05 | 89 | 200 | 7 | CID000000227 | |
| Drug | AC1NS44W | 1.44e-05 | 60 | 200 | 6 | CID005353385 | |
| Drug | H2O2 | ERBB3 ITGA5 ACE PTGS1 PTK2 STAT1 MAP3K5 MET CLCN4 CLCNKA CLCNKB MLC1 HPD ACTL6B ALDH3A1 GNAS IMMT RB1 POLD2 H6PD TXNIP DUOXA1 EGFR CSK ATP1B3 EPAS1 | 1.57e-05 | 1183 | 200 | 26 | CID000000784 |
| Drug | sucrose-6-phosphate | 1.61e-05 | 18 | 200 | 4 | CID000644101 | |
| Drug | PDE II | 1.82e-05 | 93 | 200 | 7 | CID003047060 | |
| Drug | RS-17053 | 2.02e-05 | 19 | 200 | 4 | CID003894573 | |
| Drug | Methylmercury Compounds | SLC43A2 ACAT1 PDHB MAP3K5 MET HPD PYGB DNMT1 SFTPC AKIRIN2 PPAT PRPF8 AR SLC3A1 CCNA2 TGFB2 CELSR1 EGFR SMARCE1 CTTN CDH7 | 2.08e-05 | 851 | 200 | 21 | ctd:D008767 |
| Drug | AC1L3372 | 2.28e-05 | 7 | 200 | 3 | CID000108025 | |
| Drug | imatinib | EPHB2 ERBB3 MAML1 PTK2 STAT1 MET ACTL6B RB1 TGFB2 EGFR CSK SETBP1 SMARCE1 EPHA1 | 2.90e-05 | 430 | 200 | 14 | CID000005291 |
| Drug | triphosphoinositide | EPHB2 DGKH PTK2 SCN3A SCN9A ACTL6B MPI CAPZB PLA2G4C EGFR CTTN | 3.17e-05 | 273 | 200 | 11 | CID009543520 |
| Drug | N-ethyl-N-nitrosourea | ERBB3 ABCA12 HPD HERC2 DNMT1 RB1 SLC3A1 CELSR1 MEGF8 EGFR MAP3K2 | 3.39e-05 | 275 | 200 | 11 | CID000012967 |
| Drug | Cgp77675 | 3.65e-05 | 43 | 200 | 5 | CID005311381 | |
| Drug | deltoin | 3.80e-05 | 71 | 200 | 6 | CID000021908 | |
| Drug | Deferoxamine | 4.12e-05 | 186 | 200 | 9 | ctd:D003676 | |
| Drug | Rgds Peptide | 4.25e-05 | 106 | 200 | 7 | CID000107775 | |
| Drug | Ascorbic Acid | ACE TRIP10 PTGS1 PTK2 PHGDH STAT1 MAP3K5 MET FAT1 ALPI SFTPC GPX2 TGFB2 TXNIP EGFR TOP2A EPAS1 | 4.26e-05 | 628 | 200 | 17 | ctd:D001205 |
| Drug | Endosulfan | MON2 ITGA5 NEB PTK2 ADRA1A SCN1A ALDH3A1 OTOA RB1 GPX2 LAMA4 AR GARIN2 SETBP1 | 4.42e-05 | 447 | 200 | 14 | ctd:D004726 |
| Drug | BN 52021 | 4.45e-05 | 73 | 200 | 6 | CID000065243 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.48e-05 | 188 | 200 | 9 | 4545_DN | |
| Drug | nickel subsulfide | 4.48e-05 | 188 | 200 | 9 | ctd:C017557 | |
| Drug | PHA665752 | 4.49e-05 | 23 | 200 | 4 | CID010461815 | |
| Drug | cypermethrin | 4.54e-05 | 284 | 200 | 11 | ctd:C017160 | |
| Drug | genistein | ERBB3 ITGA5 ACE ITGB3 PTGS1 PTK2 STAT1 MET CLCN4 CLCNKA CLCNKB ACTL6B DAGLA ALPI DNMT1 LAMA4 TNS2 PRPF8 AR CCNA2 TGFB2 GTF2I EGFR CSK | 4.90e-05 | 1117 | 200 | 24 | CID005280961 |
| Drug | 5-fluorouridylate | 5.35e-05 | 24 | 200 | 4 | CID000150856 | |
| Drug | Epirubicin | 5.65e-05 | 47 | 200 | 5 | ctd:D015251 | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 3377_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 4249_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 3846_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 2897_UP | |
| Drug | IN1076 | 6.04e-05 | 112 | 200 | 7 | CID000005309 | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; HL60; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 6147_DN | |
| Drug | PKI166 | 6.27e-05 | 48 | 200 | 5 | CID006918403 | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 2128_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 5285_DN | |
| Drug | Etoposide | ERBB3 RIPK2 ITGB3 PHGDH STAT1 MAP3K5 ALDH3A1 DNMT1 FLNC RB1 PAPSS2 AR CCNA2 TXNIP EGFR TOP2A | 6.64e-05 | 587 | 200 | 16 | ctd:D005047 |
| Drug | uric acid | 6.95e-05 | 199 | 200 | 9 | CID000001175 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 3360_DN | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 7.22e-05 | 200 | 200 | 9 | 2481_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | 7.22e-05 | 200 | 200 | 9 | 6907_DN | |
| Drug | arabinosyluracil | ABAT GCNT2 ALKBH8 UGT2B4 UGT2B10 PYGB PYGL IMMT MPI DPYD PPAT PRPF8 | 7.42e-05 | 354 | 200 | 12 | CID000001177 |
| Drug | 2,6-dihydroxypyridine | 7.66e-05 | 10 | 200 | 3 | CID000069371 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 7.66e-05 | 10 | 200 | 3 | ctd:C107875 | |
| Drug | 5-(2-chloroethyl)uracil | 7.68e-05 | 2 | 200 | 2 | CID010442204 | |
| Drug | 3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid | 7.68e-05 | 2 | 200 | 2 | ctd:C426703 | |
| Drug | 6878P | 7.68e-05 | 2 | 200 | 2 | CID002725013 | |
| Drug | AC1LBRFU | 7.68e-05 | 2 | 200 | 2 | CID000562981 | |
| Drug | technetium 99m (HYNIC-3PRGD(2))(tricine)(TPPTS) | 7.68e-05 | 2 | 200 | 2 | ctd:C561921 | |
| Drug | 3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid | 7.68e-05 | 2 | 200 | 2 | ctd:C478626 | |
| Drug | phosphotyrosine (pY | 8.10e-05 | 203 | 200 | 9 | CID000030819 | |
| Drug | saracatinib | 8.65e-05 | 27 | 200 | 4 | CID010302451 | |
| Drug | EGFR inhibitor | 9.35e-05 | 120 | 200 | 7 | CID009549299 | |
| Drug | Zinc Sulfate | SYNRG NCLN ZNF831 ACE PLPPR1 STAT1 MET CLCNKB HPD SCN1A DLG2 ALDH3A1 GNAS TNS3 RB1 LAMA4 CDH19 EGFR | 9.78e-05 | 739 | 200 | 18 | ctd:D019287 |
| Drug | 4-hydroxybenzyl alcohol | 1.05e-04 | 11 | 200 | 3 | CID000000125 | |
| Drug | DCDM | 1.05e-04 | 11 | 200 | 3 | CID000030814 | |
| Drug | cicaprost | 1.05e-04 | 11 | 200 | 3 | ctd:C043867 | |
| Drug | 4,5-dianilinophthalimide | 1.05e-04 | 11 | 200 | 3 | CID000001697 | |
| Drug | Capsaicin | RIPK2 ITGA5 PTK2 STAT1 ALDH3A1 RB1 CILK1 AKIRIN2 H6PD AR CCNA2 TGFB2 EGFR TRPV4 | 1.12e-04 | 488 | 200 | 14 | ctd:D002211 |
| Drug | geldanamycin | BCOR ITGB3 CCNK PTGS1 PTK2 MAP3K5 MET COL8A1 LAMA4 TGFB2 EGFR CSK | 1.16e-04 | 371 | 200 | 12 | ctd:C001277 |
| Drug | argon | 1.19e-04 | 87 | 200 | 6 | CID000023968 | |
| Drug | AC1L1G9T | ERBB3 ITGA5 PTGS1 PTK2 STAT1 MET ACTL6B ARHGAP35 TGFB2 EGFR CSK CTTN EPAS1 | 1.26e-04 | 433 | 200 | 13 | CID000003591 |
| Drug | AG213 | 1.35e-04 | 89 | 200 | 6 | CID005328803 | |
| Drug | Doxazosin | 1.71e-04 | 32 | 200 | 4 | ctd:D017292 | |
| Drug | nitrate | 1.76e-04 | 331 | 200 | 11 | CID000000943 | |
| Drug | docetaxel | 1.78e-04 | 133 | 200 | 7 | ctd:C067311 | |
| Drug | CMF regimen | 1.79e-04 | 13 | 200 | 3 | ctd:C034456 | |
| Drug | thiamine | 1.86e-04 | 134 | 200 | 7 | CID000001130 | |
| Drug | pyridoxal | 1.95e-04 | 135 | 200 | 7 | CID000001050 | |
| Drug | arsenate | 1.95e-04 | 135 | 200 | 7 | CID000000233 | |
| Drug | iodoacetamide | 2.06e-04 | 181 | 200 | 8 | CID000003727 | |
| Drug | Clioquinol | 2.14e-04 | 62 | 200 | 5 | ctd:D007464 | |
| Drug | 2-deoxy-D-arabino-hexose 6-phosphate | 2.18e-04 | 34 | 200 | 4 | CID000108108 | |
| Drug | de-E | 2.18e-04 | 34 | 200 | 4 | CID000215436 | |
| Drug | silibinin | ABAT CCNK PTGS1 UGT2B4 UGT2B10 ALPI COL8A1 COL19A1 CCNA2 EGFR | 2.25e-04 | 285 | 200 | 10 | CID000005213 |
| Drug | AC1Q69H9 | 2.26e-04 | 14 | 200 | 3 | CID000001814 | |
| Drug | 3,5-dimethylphenyl isocyanate | 2.29e-04 | 3 | 200 | 2 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 2.29e-04 | 3 | 200 | 2 | CID000147839 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 2.29e-04 | 3 | 200 | 2 | ctd:C561228 | |
| Drug | NSC758405 | 2.29e-04 | 3 | 200 | 2 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 2.29e-04 | 3 | 200 | 2 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 2.29e-04 | 3 | 200 | 2 | CID000196007 | |
| Drug | Aspaminol | 2.29e-04 | 3 | 200 | 2 | CID003084278 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 2.29e-04 | 3 | 200 | 2 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 2.29e-04 | 3 | 200 | 2 | CID000191554 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.27e-07 | 9 | 195 | 4 | C3502809 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.77e-07 | 10 | 195 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.77e-07 | 10 | 195 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | EPHB2 ERBB3 ABR NDST4 CHD3 ACE ITGB3 PHGDH MET RPRD2 DNMT1 RB1 AR EGFR SP5 TOP2A CDH12 | 8.21e-07 | 616 | 195 | 17 | C0376358 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.78e-07 | 12 | 195 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | ERBB3 ABR NDST4 CHD3 ACE ITGB3 PHGDH MET RPRD2 DNMT1 RB1 AR EGFR SP5 TOP2A CDH12 | 3.80e-06 | 616 | 195 | 16 | C0033578 |
| Disease | ductal carcinoma in situ (is_marker_for) | 5.74e-06 | 39 | 195 | 5 | DOID:0060074 (is_marker_for) | |
| Disease | Intellectual Disability | KIFBP CHD3 ALKBH8 SCN1A SCN3A ACTL6B GNAS ASCC3 BRSK2 CCNA2 FRY SETBP1 ZMYM6 | 9.67e-06 | 447 | 195 | 13 | C3714756 |
| Disease | Malignant neoplasm of breast | ERBB3 CEP85L PTGS1 PHGDH STAT1 ADRA1A ALKBH8 CDH20 UTP20 HERC2 DNMT1 DPYD COL19A1 RB1 GPX2 H6PD AR EGFR WDCP SETBP1 TOP2A | 9.76e-06 | 1074 | 195 | 21 | C0006142 |
| Disease | anxiety disorder (implicated_via_orthology) | 1.23e-05 | 22 | 195 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Neoplasm Metastasis | 1.52e-05 | 217 | 195 | 9 | C0027627 | |
| Disease | Breast Carcinoma | ERBB3 PTGS1 PHGDH ALKBH8 HERC2 DNMT1 DPYD RB1 GPX2 H6PD AR EGFR SETBP1 TOP2A | 1.53e-05 | 538 | 195 | 14 | C0678222 |
| Disease | heart failure | 3.39e-05 | 185 | 195 | 8 | EFO_0003144 | |
| Disease | Neurodevelopmental Disorders | 3.65e-05 | 93 | 195 | 6 | C1535926 | |
| Disease | Profound Mental Retardation | 4.04e-05 | 139 | 195 | 7 | C0020796 | |
| Disease | Mental deficiency | 4.04e-05 | 139 | 195 | 7 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.04e-05 | 139 | 195 | 7 | C0025363 | |
| Disease | Bartter disease type 4B | 4.35e-05 | 2 | 195 | 2 | cv:C4310805 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.35e-05 | 2 | 195 | 2 | 613090 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 4.35e-05 | 2 | 195 | 2 | C4551549 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.35e-05 | 2 | 195 | 2 | C4310805 | |
| Disease | Bartter disease (implicated_via_orthology) | 4.35e-05 | 2 | 195 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 4.35e-05 | 2 | 195 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B | 4.35e-05 | 2 | 195 | 2 | C2751312 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 4.35e-05 | 2 | 195 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | ERBB3 PTGS1 PHGDH ALKBH8 DNMT1 DPYD RB1 GPX2 H6PD AR EGFR SETBP1 TOP2A | 5.14e-05 | 525 | 195 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB3 PTGS1 PHGDH ALKBH8 DNMT1 DPYD RB1 GPX2 H6PD AR EGFR SETBP1 TOP2A | 5.14e-05 | 525 | 195 | 13 | C1257931 |
| Disease | Mammary Neoplasms | ERBB3 PTGS1 PHGDH ALKBH8 DNMT1 DPYD RB1 GPX2 H6PD AR EGFR SETBP1 TOP2A | 5.34e-05 | 527 | 195 | 13 | C1458155 |
| Disease | Adenoid Cystic Carcinoma | 5.49e-05 | 100 | 195 | 6 | C0010606 | |
| Disease | Unipolar Depression | 6.08e-05 | 259 | 195 | 9 | C0041696 | |
| Disease | Autistic Disorder | 6.45e-05 | 261 | 195 | 9 | C0004352 | |
| Disease | Head and Neck Neoplasms | 6.51e-05 | 33 | 195 | 4 | C0018671 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 7.74e-05 | 13 | 195 | 3 | C0751122 | |
| Disease | Schizophrenia | ERBB3 CMYA5 ACE ITGB3 PTGS1 MET SLC26A8 ADRA1A MLC1 DLG2 ALDH3A1 GNAS DNMT1 DPYD KMO CCNA2 PLA2G4C | 8.61e-05 | 883 | 195 | 17 | C0036341 |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 9.80e-05 | 14 | 195 | 3 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Retinoblastoma | 1.30e-04 | 3 | 195 | 2 | C0035335 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.49e-04 | 16 | 195 | 3 | C0393706 | |
| Disease | Liver carcinoma | 1.52e-04 | 507 | 195 | 12 | C2239176 | |
| Disease | Squamous cell carcinoma | 1.80e-04 | 124 | 195 | 6 | C0007137 | |
| Disease | Malignant Head and Neck Neoplasm | 2.04e-04 | 44 | 195 | 4 | C0278996 | |
| Disease | schizophrenia (is_marker_for) | 2.04e-04 | 44 | 195 | 4 | DOID:5419 (is_marker_for) | |
| Disease | Adrenocortical carcinoma | 2.16e-04 | 18 | 195 | 3 | C0206686 | |
| Disease | Malignant neoplasm of salivary gland | 2.23e-04 | 45 | 195 | 4 | C0220636 | |
| Disease | Major Depressive Disorder | 2.26e-04 | 243 | 195 | 8 | C1269683 | |
| Disease | reticulocyte measurement | SLC43A2 USP34 ACAT1 IP6K1 STAT1 MAP3K5 FAT1 CDH20 TNS3 DNMT1 MED16 ECPAS PRPF8 AR GARIN2 SLC9A5 SETBP1 AFG1L | 2.33e-04 | 1053 | 195 | 18 | EFO_0010700 |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.55e-04 | 19 | 195 | 3 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Bulbospinal Neuronopathy | 2.58e-04 | 4 | 195 | 2 | C0393547 | |
| Disease | bronchiolo-alveolar adenocarcinoma (is_marker_for) | 2.58e-04 | 4 | 195 | 2 | DOID:4926 (is_marker_for) | |
| Disease | Osteosarcoma | 2.64e-04 | 47 | 195 | 4 | C0029463 | |
| Disease | Salivary Gland Neoplasms | 2.64e-04 | 47 | 195 | 4 | C0036095 | |
| Disease | Adenocarcinoma of prostate | 2.98e-04 | 20 | 195 | 3 | C0007112 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.34e-04 | 139 | 195 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 4.29e-04 | 5 | 195 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 4.29e-04 | 5 | 195 | 2 | C0020072 | |
| Disease | blood platelet disease (is_implicated_in) | 4.29e-04 | 5 | 195 | 2 | DOID:2218 (is_implicated_in) | |
| Disease | scavenger receptor class F member 1 measurement | 4.29e-04 | 5 | 195 | 2 | EFO_0008276 | |
| Disease | fecal incontinence | 4.29e-04 | 5 | 195 | 2 | EFO_0009523 | |
| Disease | carbohydrate metabolic disorder (is_implicated_in) | 4.29e-04 | 5 | 195 | 2 | DOID:2978 (is_implicated_in) | |
| Disease | DNA methylation | AKR1D1 MDN1 TNS3 DNHD1 DPYD ADAMTSL1 AGR3 CDH19 STPG2 FRY SUN5 SMARCE1 DNAH11 | 4.53e-04 | 656 | 195 | 13 | GO_0006306 |
| Disease | hearing impairment | 4.94e-04 | 98 | 195 | 5 | C1384666 | |
| Disease | Neoplasm of the genitourinary tract | 5.19e-04 | 24 | 195 | 3 | cv:C0042065 | |
| Disease | Cancer of Head | 5.19e-04 | 24 | 195 | 3 | C0751177 | |
| Disease | Head Neoplasms | 5.19e-04 | 24 | 195 | 3 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 5.19e-04 | 24 | 195 | 3 | C0887900 | |
| Disease | Colorectal Neoplasms | 5.40e-04 | 277 | 195 | 8 | C0009404 | |
| Disease | Neck Neoplasms | 5.87e-04 | 25 | 195 | 3 | C0027533 | |
| Disease | Cancer of Neck | 5.87e-04 | 25 | 195 | 3 | C0746787 | |
| Disease | age at menarche | USP34 NDST4 SCN2A DLG2 ASCC3 DPYD RPAP3 DNAH2 ECPAS GTF2I RTL1 EPAS1 | 6.32e-04 | 594 | 195 | 12 | EFO_0004703 |
| Disease | Sensory Neuropathy, Hereditary | 6.40e-04 | 6 | 195 | 2 | C0699739 | |
| Disease | leiomyoma (is_implicated_in) | 6.40e-04 | 6 | 195 | 2 | DOID:127 (is_implicated_in) | |
| Disease | polycythemia (is_implicated_in) | 6.40e-04 | 6 | 195 | 2 | DOID:8432 (is_implicated_in) | |
| Disease | Bartter syndrome | 6.40e-04 | 6 | 195 | 2 | cv:C0004775 | |
| Disease | eye colour measurement | 6.45e-04 | 218 | 195 | 7 | EFO_0009764 | |
| Disease | Tonic - clonic seizures | 6.49e-04 | 104 | 195 | 5 | C0494475 | |
| Disease | Seizures, Focal | 6.49e-04 | 104 | 195 | 5 | C0751495 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 7.19e-04 | 61 | 195 | 4 | DOID:3021 (biomarker_via_orthology) | |
| Disease | urinary bladder cancer (is_marker_for) | 7.38e-04 | 107 | 195 | 5 | DOID:11054 (is_marker_for) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.70e-04 | 108 | 195 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | Carcinomatosis | 7.76e-04 | 163 | 195 | 6 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 7.76e-04 | 163 | 195 | 6 | C0205697 | |
| Disease | Undifferentiated carcinoma | 7.76e-04 | 163 | 195 | 6 | C0205698 | |
| Disease | Anaplastic carcinoma | 7.76e-04 | 163 | 195 | 6 | C0205696 | |
| Disease | Carcinoma | 8.01e-04 | 164 | 195 | 6 | C0007097 | |
| Disease | Epilepsy | 8.02e-04 | 109 | 195 | 5 | C0014544 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 8.24e-04 | 28 | 195 | 3 | DOID:3083 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA12 ABCA10 CDKL5 FAT1 GNAS PIGO FLNC DPYD EGFR SETBP1 IGSF21 CDH7 EPHA1 | 8.46e-04 | 702 | 195 | 13 | C0009402 |
| Disease | carcinoma (implicated_via_orthology) | 8.62e-04 | 64 | 195 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | embryonal carcinoma (is_marker_for) | 8.93e-04 | 7 | 195 | 2 | DOID:3308 (is_marker_for) | |
| Disease | heroin dependence | 8.93e-04 | 7 | 195 | 2 | EFO_0004240 | |
| Disease | Seizure, Febrile, Complex | 8.93e-04 | 7 | 195 | 2 | C0751057 | |
| Disease | vanillylmandelate (VMA) measurement | 8.93e-04 | 7 | 195 | 2 | EFO_0800119 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 8.93e-04 | 7 | 195 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 8.93e-04 | 7 | 195 | 2 | C0149886 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 8.93e-04 | 7 | 195 | 2 | DOID:8577 (implicated_via_orthology) | |
| Disease | retinal detachment | 8.93e-04 | 7 | 195 | 2 | EFO_0005773 | |
| Disease | urate measurement, bone density | TSHZ2 SLC26A8 SALL2 EHMT2 MLC1 DLG2 SCFD1 AOAH SLC26A5 EYS CDH12 DNAH11 | 9.04e-04 | 619 | 195 | 12 | EFO_0003923, EFO_0004531 |
| Disease | brain measurement, neuroimaging measurement | ERBB3 ABCF3 PTK2 PYGB DLG2 DIP2B BRSK2 EGFR ATP1B3 DNAH11 AFG1L | 1.15e-03 | 550 | 195 | 11 | EFO_0004346, EFO_0004464 |
| Disease | Idiopathic Myoclonic Epilepsy | 1.19e-03 | 8 | 195 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.19e-03 | 8 | 195 | 2 | C0338479 | |
| Disease | cervix carcinoma (is_marker_for) | 1.19e-03 | 8 | 195 | 2 | DOID:2893 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EQKGPPEGSETMPYI | 36 | Q12979 | |
| VPIMPTAGTTPDEDY | 1246 | P21860 | |
| PYIPMDGEDFQLSPI | 531 | Q99814 | |
| MKSIEDGYRLPPPVD | 836 | P21709 | |
| PIFGVDYEMEEKPQP | 261 | Q8N3I7 | |
| TLSKDYEGYPAPAMP | 1936 | Q68DQ2 | |
| PSPEYAPIFGLMQEK | 491 | P26358 | |
| GVIFPDPSGDSYKMI | 296 | Q8WWZ4 | |
| IYDLVVPFPSAPSMD | 891 | P12821 | |
| PPLSDAYLSGMPAKR | 1036 | P46379 | |
| VDALLMPPNKPYSFA | 71 | Q96BT7 | |
| VPMAFKPGDEIYPRD | 121 | P51857 | |
| SPEYMFSSNIEPEPK | 1326 | Q86UK0 | |
| PPYMIAAKEPVREGA | 216 | O94805 | |
| APAAPPAKMAAELYA | 46 | Q96KE9 | |
| ASPQKYLRMEPSPFG | 56 | Q53H80 | |
| PDGQYVPRIMFVDPS | 111 | Q8TD06 | |
| VMPIGSFFPDFKPSE | 291 | P35348 | |
| DEGLKVRYPPSPAKM | 436 | P30838 | |
| AINYKGPPFMESLPE | 1116 | Q9HD20 | |
| VVMKFPDGFEKFSPP | 476 | Q9NUQ8 | |
| ATLDDMEKPPYFPPN | 2016 | Q8WXG9 | |
| PGFMAKSYDPIAPIA | 186 | Q8WV93 | |
| MKTEGPSYGALPPAY | 451 | O75909 | |
| PYEEAQGPEMLTPVS | 2421 | Q8IYW2 | |
| EDELMLAPGFAAPPY | 4171 | Q96DT5 | |
| DAPDGCPPAVYEVMK | 406 | P41240 | |
| LPPPEKMSEAYSAKI | 176 | Q12882 | |
| PSEYMEVPLGSLELP | 381 | Q96KQ7 | |
| NSIMYFTEEPPELPA | 671 | P51793 | |
| PVPQFRIDPDSGTMY | 831 | Q9NYQ6 | |
| RPLDENTYAPTMPFK | 4066 | Q96M86 | |
| MEGATPAIYPFLDSP | 196 | Q6W2J9 | |
| DPSSGYIIVKVPPDM | 321 | Q8N7E2 | |
| SNKYDPPLEDGAMPS | 76 | P47756 | |
| EPEPSPFSSKRTMYE | 771 | Q2TAZ0 | |
| KPYPASIPELASTEM | 846 | Q9C0F0 | |
| SPYKISEGLPTPTKM | 811 | P06400 | |
| ATVGPPPDTYMKASA | 301 | Q8N684 | |
| YEKMVAVDPGAPTPE | 511 | Q96DU7 | |
| IYNLTEKGTPPDMPV | 426 | Q969V3 | |
| DPVPAMTTPEKLYSN | 381 | P28039 | |
| ATSYPPMFTQDPKAG | 81 | Q9UKY3 | |
| EPGPYFMEPEIKICF | 126 | Q9P2P5 | |
| RNSSDKIPSYDPMPG | 811 | Q7RTW8 | |
| PEMQLPKFSEPFYTF | 2696 | Q14517 | |
| DVPYPMEKPASPSSY | 441 | Q92585 | |
| ENELMYGVPFEFPPE | 201 | P11177 | |
| TIVAIFPSPMLYAGP | 476 | O95340 | |
| GMPHPETKKDLYEPT | 516 | O95340 | |
| APSDLMVKPDGPYDF | 3701 | Q9NU22 | |
| IPAIMDTYPVDQGPK | 1281 | Q5T1H1 | |
| FPGPYAVLTKDTMPQ | 256 | Q14774 | |
| TFPTMDPKPLAYAIQ | 366 | Q7Z3F1 | |
| PASAGKLPAQVPMEY | 4321 | O95714 | |
| KTPPPHDMVIYFGTA | 251 | Q8N0V5 | |
| LEPFPGPEDMDYSVK | 231 | Q8N370 | |
| MPFITTIPGGLYPSK | 226 | Q6DKI2 | |
| MPFITTIPGGLYPSK | 226 | Q3B8N2 | |
| YDGPLMKTEVPGPRS | 41 | P80404 | |
| EFLDPLMGAAAPQYP | 731 | Q96Q04 | |
| PPYFAEKIILTEMPG | 341 | Q8NDZ0 | |
| EYPTGKDTAKMGPPT | 716 | Q8IWQ3 | |
| YVKALEEGPVNPMTP | 381 | Q6UXY1 | |
| LDPCPASDGYKQIMP | 356 | Q8N6G6 | |
| IQRASYMPPKDPGYS | 401 | Q7L5Y1 | |
| QPPPGMSFYAAKRVI | 216 | Q5VYK3 | |
| PVDVMPGEFDPTNYT | 291 | P49005 | |
| PGMKIYIDPFTYEDP | 591 | P29323 | |
| VRYMPPEEGPYKVDI | 1026 | Q14315 | |
| DSPLDGESYPKSRMP | 221 | Q9Y2U5 | |
| KPPTPEMLAYLDFSV | 1146 | Q9P265 | |
| PRGDLMAYKVPPFVF | 536 | Q7Z7M0 | |
| FEMVLGPAAYNVPLP | 86 | Q16891 | |
| RVPYPSPTCVKSEMG | 511 | P10275 | |
| LDKVEPPTIPEGYAM | 471 | Q7Z3U7 | |
| KYPPMDPESRTFLSN | 826 | Q9H3R1 | |
| KTMLTPGPGDYFPEK | 96 | Q96PU9 | |
| FRVDSTPGPAAYMLP | 131 | Q96PU9 | |
| LDGEMYPPSVEEAPV | 256 | P23219 | |
| SLLPGPPEASEEFYM | 471 | Q86XP1 | |
| SIYDPPVPDFTIMKT | 336 | P34949 | |
| MVFPAGILQPTLYDP | 581 | O95672 | |
| YCMPEEGVPLTPKAN | 86 | Q9NZB8 | |
| YSSAAPRPVDEPAMK | 406 | Q9Y2X0 | |
| KLGPETPLAMDRFPY | 81 | P09923 | |
| KETLFYICGPPPMTD | 276 | Q96HP4 | |
| PYGTAMEKAQLKPPA | 1031 | P08648 | |
| SNMKKPVEEGTLPYP | 156 | Q9UP65 | |
| ELMTFGSKPYDGIPA | 906 | P00533 | |
| KPAPMVYFKRDGEPI | 176 | Q96ID5 | |
| ELTIPPKNGDYAMEP | 196 | O15229 | |
| IPTQDSAKVDPPEYM | 71 | O95393 | |
| PYFDLPAGLMAPLVK | 646 | Q8IWX8 | |
| IFPKGLPEEYSVAAM | 91 | Q14993 | |
| LDGPYVATVPEMSPV | 166 | Q9HBT6 | |
| PVAAMESPKLPSGAY | 1036 | Q12873 | |
| PEMFVPDLTPTFYGA | 486 | Q8NCL4 | |
| PNVPESEMKYSVLPD | 1231 | Q8N3K9 | |
| PVDMTYSALPESKPI | 251 | Q5SZL2 | |
| PAYEMPAFTAELTAP | 611 | P27658 | |
| PYGGVAPALKEVSMP | 181 | Q7KYR7 | |
| YFAPRGLPPMEKNVV | 271 | Q6UXX5 | |
| MVVPESPTSDYAEGP | 936 | Q9Y4D2 | |
| AFVDKPVSPYMYISP | 181 | P05106 | |
| SLPPEMKEFTPEYKG | 61 | Q92551 | |
| PPPYFNESIVVDMKS | 411 | Q9BVP2 | |
| EPMYIYISHPKPEGL | 291 | Q7Z7F0 | |
| LDGPYVATVPEMSPV | 161 | P55289 | |
| VGKPTTIYMTDPYGP | 276 | Q15700 | |
| MLPINVDPDSKPGEY | 51 | Q5TBA9 | |
| PKFLDGPYTAGVPEM | 151 | Q9ULB5 | |
| VDEPPVFSSPLYPME | 371 | Q9ULB5 | |
| LVPLDYPMDGSFESP | 141 | P20248 | |
| PYDDPFSLMTDPKLI | 126 | P18283 | |
| QKPGKLSDMYPSTVP | 786 | Q9Y3R0 | |
| VDGMPPGVSFKAPSY | 906 | P78347 | |
| PAPMPSDFQVLRAKY | 536 | O95479 | |
| EEMPNGVPPEKVKSY | 101 | O76039 | |
| PNAPFYKIMVPTVDT | 2381 | Q9P225 | |
| KEYISLLPGMDPPEA | 4096 | Q9P225 | |
| YAGPKPTFPMDTTLA | 11 | Q1HG43 | |
| SESPYKQPSDGMERP | 796 | Q5VT52 | |
| SVKMYGSAVPPAAPT | 801 | O95104 | |
| PYGMSVPPEKAEEEA | 451 | Q9Y467 | |
| EPYEAIVPEMSPEGT | 151 | Q9H159 | |
| QYMKEVGSPPLDPTE | 171 | Q96EK5 | |
| PPYPCIETGDSKMNL | 161 | Q96HA8 | |
| MKPIATVGESYQYPP | 1391 | Q5VW36 | |
| KEVLMESPPDYSAAP | 6 | P11686 | |
| TMKNPKVEVFGYPPS | 216 | Q2NL67 | |
| MKIPFTDIYIGGAPP | 1166 | Q16363 | |
| IIEMATGKPPFYELG | 871 | Q99683 | |
| TTPEPGIYMFNMEPS | 31 | P0C841 | |
| FLPGYEAPAFMDPLL | 156 | P32754 | |
| GEYAPFVSPPMLESN | 36 | Q8N9W8 | |
| DPVITSISPKYGPMA | 656 | P08581 | |
| MGGTDPFKYSYPPLV | 231 | Q8NHP6 | |
| EMKSYQPFALSPDPI | 696 | A6NKG5 | |
| PGEKKDVSGPMPDSY | 286 | P26640 | |
| PPTAGSMAIEKYPLV | 456 | O75691 | |
| EAALLKGPSPEPMYA | 56 | Q9BWW7 | |
| PADPSYPYEFSPVKM | 116 | Q6BEB4 | |
| YSRPKEAPEPMELDG | 681 | P42224 | |
| MFSKAPITYVPPEDR | 286 | Q8IYX7 | |
| KGEPYMSIQPAEDPD | 166 | Q969G3 | |
| PLPGTKALPSMDKYA | 501 | Q9UMZ2 | |
| PKYQAEFPMSPVTSA | 376 | O75019 | |
| GMSSYEFPPALKPPE | 301 | O15226 | |
| IDMIPYSFLLPVTPD | 336 | Q96RN1 | |
| YPPIVIKSTFPEEMQ | 616 | P58743 | |
| IEMSSKIQPAPPEEY | 936 | Q05397 | |
| YSPPPEETMPFELDG | 216 | Q5JWF2 | |
| FIYGDIPPGMVSEPL | 61 | Q15858 | |
| LLPPIVLDSGYFMPS | 111 | Q14940 | |
| EPDFKGVQPYAGMPK | 56 | Q07837 | |
| EPIDFPIAPVYAASM | 321 | P24752 | |
| LPFIYGDIPPEMVSE | 61 | Q9NY46 | |
| SPADVKETMTPGYPQ | 811 | Q68CZ2 | |
| MKPYPGTEEESFITP | 56 | Q8TBJ4 | |
| MKSFFSELPDPLVPY | 1321 | Q9NRY4 | |
| LPFIYGDIPPEMVSE | 61 | P35498 | |
| GPYPSESAMTKAVFP | 61 | Q08188 | |
| IPSYLNDEPPEGSMK | 11 | Q8WUH6 | |
| SEPMPLSFEEKPVYI | 446 | Q8N3C0 | |
| KYRDQIPSPGLMVFP | 71 | P54709 | |
| YEKTPQMGDPASLEP | 431 | Q15642 | |
| IPDPSPGYSSLKAMR | 576 | Q9UPZ9 | |
| ATTIPMPAGYFMPIF | 416 | P51800 | |
| ATTIPMPAGYFMPIF | 416 | P51801 | |
| GPLAPLPDYMSEEKL | 16 | Q6P2Q9 | |
| KEVYKIDMPPFFPSE | 101 | P61812 | |
| TAPKDFVIYGMEGSP | 291 | Q8TC36 | |
| GLLFPPSYVPVVMSE | 186 | P06133 | |
| YTKGMDADPYNPVLP | 156 | Q9H6T3 | |
| PVSGTEPEPVYSMEA | 436 | Q14247 | |
| FLPMKSITPAPGTYN | 206 | Q8N412 | |
| SKSAPEGGTIIYMPP | 181 | O43353 | |
| EKYSFRGFPPEDLMP | 21 | Q92791 | |
| RVASPPIKYPCFMGI | 416 | Q06203 | |
| SLPFIYGDIPPEMVS | 61 | Q99250 | |
| VVLAMPYDTPVPGYK | 221 | P11216 | |
| PEGFGLEPKPRMSTY | 2076 | Q6ZS81 | |
| DPIPDVPAVYFVMPT | 81 | Q8WVM8 | |
| PDKLPGFKMYPIDFE | 836 | P22314 | |
| AAYQLSEGTKPPLPM | 546 | Q9NRE2 | |
| DGEEPLPMLPSYKNF | 881 | P11388 | |
| PPYALGKSLRPSAEM | 271 | O95789 | |
| FIFPPSYVPVVMSKL | 186 | P36537 | |
| YGNLKSPEPPMLFVR | 691 | Q8TEQ8 | |
| SFGMKTIGYDPIISP | 166 | O43175 | |
| PMSLGPYFPCRENIK | 3086 | Q70CQ2 | |
| PAQMSKFSYPTVPGV | 1241 | Q5JPB2 | |
| PNSKDMTPYALPVIG | 241 | Q9H6R7 | |
| KFMPPPTYTEVDPCI | 371 | Q9H3M7 | |
| SDKLMLEPPSAYPIT | 551 | Q9Y6X0 | |
| VVLALPYDTPVPGYM | 221 | P06737 | |
| MPKPPDYSELSDSLT | 1 | Q8N6I4 | |
| YESSVVPGPKKAPMD | 91 | Q9HBA0 | |
| VPGPKKAPMDSLFDY | 96 | Q9HBA0 | |
| SFAMEKKPPCGSTPY | 606 | O15231 | |
| SLSEGLYPYPPEMGK | 646 | Q63HR2 | |
| PGYPLPKLDMNFSLE | 186 | Q6P9G9 | |
| LFYVGEPKMDTTPPA | 646 | A6NCI4 | |
| GYKMPDVPDAFPELS | 221 | Q8NEZ2 | |
| GVYSMPAGTKVFEVP | 526 | Q9H808 | |
| PIFYCSFPTRMPGDK | 491 | Q9BRZ2 | |
| IVEMFKDYPPAIKPS | 286 | Q15049 | |
| GKPMLDFETPTYITA | 5911 | P20929 | |
| PTEDPTMERPYTFKD | 116 | Q96PU5 |